rfhg_18248.1

Basic information about the TSS

---

TSS ID: rfhg_18248.1 Species: human Chr: chr1		Start: 202958245 End: 202958253 Strand: -
Source datasets	FANTOM5
Protocol	CAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	PLS,CTCF-bound (EH38D2263734,EH38E1413056)
Category:	PLS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: AF125179:0 AF125180:0 GeneID: 51094 HGNC/MGI_ID: HGNC:24040 UniProt_ID: Q2V062 Nearer transcript ids and distances: ENST00000367254.7:-11 AY424279:13 AK222503:-17 AF151803:-28 BC010743:-30 ENST00000426229.1:-32 BC001594:-36 ENST00000340990.10:-59 NM_015999.6:-59 AK001484:-59 AK058114:-59 LF205361:-142 MA440938:-142 NM_001290557.1:-143 NM_001290553.2:261 ENST00000417068.5:-319 NM_001290629.1:-319 view more...

Gene_name: adiponectin receptor 1 Gene_symbol: ADIPOR1 Gene_synonyms: ACDCR1 PAQR1 Gene_source: HGNC:24040

TATA-Box annotation

---

Distance to TSS:	63
Nearest PromoterID:	NM_015999
Entrez ID:	51094
Nearest Unigene:	Hs.5298
Nearest Refseq:	NM_015999
Nearest Ensembl:	ENSG00000159346
Gene Name:	adiponectin receptor 1
Gene Alias:	ACDCR1|CGI-45|CGI45|PAQR1|TESBP1A
Gene Type:	protein-coding
CpG%:	0.125000
GC%:	0.888889
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@ADIPOR1 p2@ADIPOR1 p4@ADIPOR1 p5@ADIPOR1
Sample		p1@ADIPOR1	p2@ADIPOR1	p4@ADIPOR1	p5@ADIPOR1
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	37.60	9.35	0.97	0.00
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	36.42	10.52	0.61	0.61
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	43.02	9.65	0.96	0.39
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	28.48	8.32	0.62	0.21
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	37.12	10.35	1.57	0.22
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	37.02	8.14	1.55	0.19
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	40.96	11.55	0.44	0.22
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	35.61	9.93	0.24	0.48
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	35.48	11.75	0.85	0.00
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	19.13	5.80	0.58	0.58
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	14.15	6.47	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	18.29	7.32	0.41	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	28.85	0.64	0.32	0.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	27.66	1.35	0.45	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	25.47	0.44	0.44	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	20.62	0.50	0.25	0.25
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	25.55	0.44	0.22	0.87
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	26.15	0.42	0.42	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	19.19	1.07	1.07	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	23.92	0.90	0.45	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	27.00	0.53	0.53	0.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	22.61	0.35	0.17	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	23.65	0.78	0.65	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	20.63	0.24	0.24	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	19.87	1.03	0.52	0.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	21.52	0.95	0.00	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	20.33	1.10	0.00	0.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	29.70	1.65	0.71	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	24.71	0.65	0.65	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	25.70	0.72	0.18	0.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	23.03	0.63	0.63	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	22.27	0.78	0.39	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	25.32	0.21	0.63	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	23.09	0.33	0.16	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	24.87	0.56	0.56	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	23.19	0.57	0.38	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	22.28	0.20	0.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	24.58	1.21	0.00	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	25.93	0.00	0.54	1.08
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	16.32	1.20	0.48	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	26.11	0.47	0.24	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	19.32	0.29	0.29	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	22.57	0.84	0.21	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	18.71	0.17	0.17	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	25.30	0.80	0.00	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	21.64	0.70	0.47	0.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	17.51	1.68	0.00	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	17.88	0.30	1.19	0.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	22.02	1.44	0.48	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	20.83	0.81	0.00	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	18.86	0.41	0.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	19.79	0.67	0.22	0.67
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	27.98	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	33.00	0.71	1.06	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	25.85	0.66	0.66	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	5.87	0.00	0.84	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	12.40	0.00	0.46	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	23.34	1.30	0.00	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	24.41	1.61	0.32	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	16.03	0.63	0.00	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	25.38	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	23.55	2.24	1.12	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	15.92	0.00	0.00	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	16.99	1.02	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	25.99	0.65	0.65	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	30.53	0.35	0.35	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	48.49	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	39.49	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	37.05	1.46	0.98	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	33.72	0.99	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	30.49	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	23.18	0.99	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	37.43	0.93	0.62	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	45.56	0.31	0.61	0.92
Adipocyte - breast, donor1	11376-118A8	43.87	0.79	0.95	0.63
Adipocyte - breast, donor2	11327-117E4	38.02	1.28	0.96	0.48
Adipocyte - omental, donor1	11473-119C6	49.62	2.42	1.02	0.64
Adipocyte - omental, donor2	11474-119C7	37.37	0.75	0.75	1.49
Adipocyte - omental, donor3	11475-119C8	27.46	0.33	0.33	0.67
Adipocyte - perirenal, donor1	11476-119C9	40.83	1.28	1.28	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	23.09	3.30	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	30.26	2.71	1.35	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	33.54	1.22	0.52	0.17
Adipocyte differentiation, day04, donor1	13019-139D4	53.00	1.96	0.78	0.98
Adipocyte differentiation, day04, donor2	13022-139D7	34.49	1.80	1.03	0.26
Adipocyte differentiation, day04, donor3	13025-139E1	37.08	1.95	0.28	0.28
Adipocyte differentiation, day04, donor4	13028-139E4	39.97	1.18	1.76	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	56.79	1.53	1.53	0.64
Adipocyte differentiation, day08, donor2	13023-139D8	41.64	2.90	2.26	0.32
Adipocyte differentiation, day08, donor3	13026-139E2	27.19	1.07	1.07	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	33.94	1.11	0.56	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	45.33	2.50	1.25	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	33.66	3.27	1.51	0.50
Adipocyte differentiation, day12, donor3	13027-139E3	37.96	0.98	1.31	0.65
Adipocyte differentiation, day12, donor4	13030-139E6	25.58	1.22	0.61	0.30
Alveolar Epithelial Cells, donor1	11510-119G7	60.55	3.31	2.43	0.88
Alveolar Epithelial Cells, donor2	11590-120G6	41.60	2.87	0.00	1.08
Alveolar Epithelial Cells, donor3	11671-122G6	20.37	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	57.93	5.40	2.16	1.44
Amniotic Epithelial Cells, donor2	11613-122A2	43.51	6.69	1.67	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	50.33	3.08	1.23	2.26
Anulus Pulposus Cell, donor1	11248-116E6	20.48	1.03	0.23	0.00
Anulus Pulposus Cell, donor2	11463-119B5	18.61	0.00	0.49	0.24
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	24.71	1.35	0.90	0.90
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	35.60	1.74	0.00	0.87
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	21.40	2.14	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	29.59	2.09	0.30	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	18.97	2.53	1.26	2.53
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	23.10	2.64	1.98	1.32
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	27.29	1.62	0.97	0.32
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	29.13	0.97	0.49	0.97
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	35.04	0.59	1.19	1.19
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	29.38	1.13	1.13	1.13
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	26.85	2.18	0.00	0.73
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	25.08	3.76	0.00	1.25
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	43.98	2.47	0.99	1.48
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	23.20	2.73	2.73	1.36
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	28.05	1.81	1.36	0.45
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	23.04	1.07	2.68	1.07
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	28.72	1.13	0.94	0.94
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	29.40	2.14	1.34	1.07
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	27.31	0.98	0.98	0.98
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	38.31	1.99	0.66	1.82
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	20.41	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	14.16	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	34.31	1.54	0.69	1.54
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	25.17	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	25.24	0.97	1.94	0.49
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	40.60	1.14	0.76	1.52
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	24.23	3.63	0.00	2.42
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	28.50	2.85	1.71	1.14
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	38.91	2.57	0.43	1.28
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	29.94	0.52	0.26	2.58
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	29.56	2.82	2.35	0.47
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	34.08	1.93	0.64	1.29
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	14.27	0.00	1.43	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	30.42	1.17	1.75	1.17
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	31.31	1.81	0.90	0.90
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	30.89	2.38	1.19	2.38
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	30.51	2.54	1.53	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	33.11	3.57	1.78	1.02
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	27.96	1.91	0.64	1.27
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	19.42	2.16	0.86	0.43
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	34.08	1.27	0.64	0.21
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	26.10	0.58	1.16	0.29
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	17.01	0.94	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	37.80	2.54	1.02	0.51
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	34.75	0.00	0.00	2.32
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	29.58	2.11	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	31.95	2.36	1.93	1.07
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	32.49	0.60	1.20	1.20
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	23.33	0.73	0.00	0.73
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	37.70	2.53	2.30	0.46
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	22.95	2.55	2.55	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	34.07	1.53	2.03	1.27
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	42.73	1.65	1.86	1.65
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	29.68	0.92	0.61	1.53
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	32.50	1.91	0.96	1.43
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	33.26	0.22	0.89	1.11
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	30.52	3.05	0.00	1.53
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	22.16	1.11	1.11	1.11
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	42.90	1.85	0.00	0.26
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	31.62	0.73	2.54	0.73
Astrocyte - cerebellum, donor1	11500-119F6	26.53	1.97	0.25	0.25
Astrocyte - cerebellum, donor2	11580-120F5	32.18	1.71	0.34	0.51
Astrocyte - cerebellum, donor3	11661-122F5	29.57	1.26	0.21	0.42
Astrocyte - cerebral cortex, donor1	11235-116D2	28.93	1.05	0.35	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	30.90	1.94	0.16	0.16
Astrocyte - cerebral cortex, donor3	11392-118C6	35.50	1.49	0.45	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	54.02	2.29	0.23	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	46.60	3.01	1.00	0.13
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	42.56	3.19	0.68	0.00
Basophils, donor1	12241-129G9	73.23	3.14	2.62	0.52
Basophils, donor2	12242-129H1	62.42	2.16	3.25	0.00
Basophils, donor3	12243-129H2	94.08	3.38	4.85	0.44
Bronchial Epithelial Cell, donor1	11511-119G8	70.72	3.45	1.72	3.67
Bronchial Epithelial Cell, donor2	11591-120G7	38.40	1.37	0.91	1.37
Bronchial Epithelial Cell, donor3	11672-122G7	21.52	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	38.29	3.14	3.14	1.26
Bronchial Epithelial Cell, donor5	11457-119A8	51.99	2.50	1.46	1.25
Bronchial Epithelial Cell, donor6	11461-119B3	33.62	3.22	1.61	1.15
Bronchial Epithelial Cell, donor7	11769-123I5	46.61	4.14	1.26	0.72
Burkitt's lymphoma cell line:DAUDI	10422-106C8	36.79	2.68	1.03	0.41
Burkitt's lymphoma cell line:RAJI	10476-106I8	53.80	2.33	0.47	0.23
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	36.13	1.60	0.32	0.64
CD133+ stem cells - cord blood derived, pool1	12223-129E9	93.08	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	77.21	1.69	2.82	0.00
CD14+ Monocytes, donor2	11305-117B9	89.09	3.53	3.71	0.74
CD14+ Monocytes, donor3	11381-118B4	80.79	1.76	3.07	0.66
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	148.03	9.91	8.49	1.42
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	148.60	6.07	9.10	1.14
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	185.41	8.88	7.89	2.30
CD14+ monocytes - mock treated, donor1	11863-125A9	89.62	4.34	7.37	1.88
CD14+ monocytes - mock treated, donor2	11873-125C1	52.50	2.41	3.32	0.91
CD14+ monocytes - mock treated, donor3	11883-125D2	59.70	3.32	3.79	1.42
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	68.30	2.68	5.02	0.33
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	45.54	2.76	5.80	0.55
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	66.94	2.23	6.69	0.25
CD14+ monocytes - treated with BCG, donor1	11860-125A6	59.52	4.11	3.33	0.59
CD14+ monocytes - treated with BCG, donor2	11870-125B7	45.05	1.96	0.89	0.00
CD14+ monocytes - treated with BCG, donor3	11880-125C8	60.72	0.44	3.92	0.00
CD14+ monocytes - treated with Candida, donor1	11868-125B5	57.13	2.58	4.68	0.70
CD14+ monocytes - treated with Candida, donor2	11878-125C6	46.99	1.58	4.22	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	54.36	1.11	1.11	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	83.00	2.97	6.99	1.49
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	61.46	4.99	5.19	0.60
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	65.58	2.91	7.29	0.42
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	70.69	3.89	5.72	0.69
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	47.96	2.04	2.94	0.23
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	47.57	2.18	3.06	0.44
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	63.21	1.61	5.38	0.54
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	51.12	1.40	2.79	0.35
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	53.02	2.95	4.21	0.42
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	67.42	2.57	3.67	0.37
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	50.73	5.99	5.28	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	56.60	4.83	2.63	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	55.28	1.57	4.53	0.17
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	44.23	1.12	2.23	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	60.78	2.59	4.31	0.65
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	63.88	2.46	2.05	0.41
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	44.27	2.09	2.09	0.23
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	44.31	2.09	2.78	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	46.21	0.87	1.74	0.44
CD14+CD16+ Monocytes, donor2	11801-124D1	50.82	1.39	2.77	0.46
CD14+CD16+ Monocytes, donor3	11912-125G4	54.37	1.95	1.95	0.87
CD14+CD16- Monocytes, donor1	11788-124B6	98.10	3.27	4.67	1.40
CD14+CD16- Monocytes, donor2	11799-124C8	80.86	2.45	4.37	0.00
CD14+CD16- Monocytes, donor3	11910-125G2	83.61	4.68	4.46	0.89
CD14-CD16+ Monocytes, donor1	11790-124B8	43.89	1.28	2.30	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	48.30	1.10	1.32	0.22
CD14-CD16+ Monocytes, donor3	11911-125G3	44.00	2.74	1.68	0.63
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	34.55	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	43.39	1.36	0.00	0.68
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	50.74	2.07	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	46.37	2.67	1.60	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	38.60	1.07	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	44.92	0.70	1.40	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	30.59	1.57	1.57	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	46.14	1.32	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	47.67	0.00	0.00	0.82
CD19+ B Cells, donor2	11624-122B4	50.78	2.18	1.45	0.00
CD19+ B Cells, donor3	11705-123B4	52.00	1.01	1.01	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	330.52	96.57	6.87	7.68
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	290.83	73.91	6.39	9.99
CD34+ Progenitors, donor1	11545-120B6	43.17	2.01	3.01	0.00
CD34+ Progenitors, donor2	11625-122B5	43.82	0.56	2.81	1.12
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	45.47	2.25	1.13	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	32.47	0.90	0.68	0.45
CD4+ T Cells, donor1	11225-116C1	77.12	2.14	3.21	0.36
CD4+ T Cells, donor2	11306-117C1	72.26	2.45	1.22	0.00
CD4+ T Cells, donor3	11382-118B5	54.90	1.83	1.52	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	35.99	0.00	0.51	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	38.41	0.90	0.67	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	41.68	0.86	0.29	0.29
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	49.78	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	46.35	1.40	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	49.44	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	38.73	0.72	0.43	0.87
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	40.16	1.19	0.51	0.34
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	40.79	0.81	0.32	0.32
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	32.28	1.34	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	41.23	0.00	0.00	0.70
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	33.88	0.44	1.76	0.44
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	33.31	1.26	0.42	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	38.85	0.42	0.21	0.21
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	25.06	1.00	0.33	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	54.11	1.36	0.54	0.27
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	53.59	3.75	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	35.86	1.79	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	41.54	1.30	0.00	0.93
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	46.36	1.73	1.08	0.22
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	48.33	1.47	0.84	0.21
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	42.47	0.51	0.51	0.51
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	42.89	0.43	0.87	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	42.27	1.31	0.44	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	51.96	4.45	0.49	0.49
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	33.23	0.92	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	61.42	0.00	2.79	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	48.19	1.11	0.83	0.28
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	44.91	1.47	0.49	0.49
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	53.90	1.54	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	55.15	1.07	0.36	0.36
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	47.09	0.00	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	68.75	3.60	2.95	0.65
CD8+ T Cells, donor2	11307-117C2	57.44	0.38	3.38	0.75
CD8+ T Cells, donor3	11383-118B6	66.66	0.76	3.03	0.25
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	41.52	1.84	0.46	0.00
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	39.06	0.48	0.72	0.00
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	30.92	0.55	0.55	0.00
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	39.33	0.30	0.90	0.00
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	32.88	1.68	1.20	0.00
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	37.97	1.59	0.91	0.00
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	39.55	1.30	1.09	0.22
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	41.06	1.05	1.58	0.79
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	44.56	0.70	2.11	0.00
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	39.85	0.30	2.11	0.00
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	36.02	0.87	1.45	0.29
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	46.09	1.07	0.53	0.53
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	40.27	0.88	1.31	0.44
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	35.52	0.46	0.91	0.46
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	23.87	1.49	2.24	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	44.66	1.08	0.36	0.72
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	31.36	0.86	0.86	0.29
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	37.24	0.47	0.94	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	38.66	1.58	1.27	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	44.90	0.31	0.31	0.62
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	44.56	2.24	1.60	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	44.37	0.76	0.38	0.38
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	35.08	1.58	1.58	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	26.47	0.76	2.27	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	35.33	1.61	2.41	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	30.77	2.10	4.90	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	49.09	0.00	0.00	0.00
Cardiac Myocyte, donor1	11525-119I4	16.45	0.00	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	18.78	0.49	0.49	0.00
Cardiac Myocyte, donor3	11686-122I3	46.41	2.53	0.63	0.53
Chondrocyte - de diff, donor1	11261-116G1	18.72	1.73	0.00	0.00
Chondrocyte - de diff, donor2	11338-117F6	33.41	0.36	0.71	0.00
Chondrocyte - de diff, donor3	11410-118E6	34.82	1.25	0.68	0.91
Chondrocyte - re diff, donor2	11339-117F7	45.66	0.90	2.69	0.00
Chondrocyte - re diff, donor3	11411-118E7	62.68	2.02	0.00	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	24.33	0.69	0.34	0.11
Ciliary Epithelial Cells, donor2	11323-117D9	24.80	0.86	0.21	0.00
Ciliary Epithelial Cells, donor3	11399-118D4	27.70	0.62	0.27	0.18
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	64.28	4.86	1.83	1.19
Corneal Epithelial Cells, donor1	11526-119I5	106.71	5.27	2.42	1.98
Corneal Epithelial Cells, donor2	11606-120I4	83.04	7.96	1.14	0.00
Corneal Epithelial Cells, donor3	11687-122I4	66.72	5.88	1.79	1.02
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	67.85	2.97	1.82	0.33
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	63.08	2.52	2.21	1.58
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	55.21	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	67.93	3.56	1.30	0.32
Dendritic Cells - plasmacytoid, donor1	11228-116C4	52.95	0.68	0.34	0.34
Dendritic Cells - plasmacytoid, donor2	11309-117C4	53.54	0.65	0.65	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	40.65	0.97	0.48	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	39.19	2.00	0.67	0.67
Endothelial Cells - Aortic, donor1	11263-116G3	37.55	0.59	0.00	0.59
Endothelial Cells - Aortic, donor2	11340-117F8	49.21	0.57	0.85	1.41
Endothelial Cells - Aortic, donor3	11412-118E8	40.10	0.79	0.39	0.00
Endothelial Cells - Artery, donor1	11264-116G4	34.03	0.87	0.58	1.16
Endothelial Cells - Artery, donor2	11341-117F9	39.29	0.47	1.41	0.71
Endothelial Cells - Artery, donor3	11413-118E9	37.17	0.88	2.10	0.18
Endothelial Cells - Lymphatic, donor1	11236-116D3	27.26	0.44	1.33	1.11
Endothelial Cells - Lymphatic, donor2	11317-117D3	39.25	0.61	1.52	0.30
Endothelial Cells - Lymphatic, donor3	11393-118C7	46.51	0.85	1.41	0.56
Endothelial Cells - Microvascular, donor1	11265-116G5	32.68	0.89	1.19	3.27
Endothelial Cells - Microvascular, donor2	11342-117G1	42.17	0.52	1.04	1.04
Endothelial Cells - Microvascular, donor3	11414-118F1	46.22	0.71	0.85	2.41
Endothelial Cells - Thoracic, donor1	11266-116G6	36.81	1.60	1.20	1.20
Endothelial Cells - Thoracic, donor2	11343-117G2	30.40	0.52	1.05	0.52
Endothelial Cells - Umbilical vein, donor1	11243-116E1	43.98	0.87	1.12	0.25
Endothelial Cells - Umbilical vein, donor2	11324-117E1	29.11	0.65	0.65	0.22
Endothelial Cells - Umbilical vein, donor3	11400-118D5	42.50	1.22	1.10	0.61
Endothelial Cells - Vein, donor1	11267-116G7	27.30	0.00	2.28	1.14
Endothelial Cells - Vein, donor2	11344-117G3	41.91	0.70	0.70	0.00
Endothelial Cells - Vein, donor3	11416-118F3	43.33	0.94	0.63	0.47
Eosinophils, donor1	12244-129H3	45.74	15.25	15.25	0.00
Eosinophils, donor2	12245-129H4	542.94	36.31	56.11	6.60
Eosinophils, donor3	12246-129H5	403.05	7.13	82.04	7.13
Esophageal Epithelial Cells, donor1	11507-119G4	63.52	5.38	2.20	0.73
Esophageal Epithelial Cells, donor2	11587-120G3	31.20	6.24	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	81.34	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	36.54	0.82	0.82	0.41
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	33.83	0.77	0.88	0.55
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	37.27	2.06	0.43	0.33
Fibroblast - Aortic Adventitial, donor1	11245-116E3	40.99	2.43	0.49	0.61
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	16.79	0.68	0.14	0.27
Fibroblast - Aortic Adventitial, donor2	11326-117E3	33.64	1.69	0.63	0.21
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	11.59	1.32	0.00	0.00
Fibroblast - Aortic Adventitial, donor3	11401-118D6	39.86	1.00	0.00	0.33
Fibroblast - Cardiac, donor1	11268-116G8	32.66	1.81	0.00	1.81
Fibroblast - Cardiac, donor2	11345-117G4	41.69	1.52	0.00	0.76
Fibroblast - Cardiac, donor3	11417-118F4	40.85	1.58	0.95	1.10
Fibroblast - Cardiac, donor4	11452-119A3	42.13	0.30	0.61	1.21
Fibroblast - Cardiac, donor5	11456-119A7	33.50	2.03	0.25	0.76
Fibroblast - Cardiac, donor6	11460-119B2	31.99	1.21	0.15	0.15
Fibroblast - Choroid Plexus, donor1	11492-119E7	29.48	1.07	0.27	0.27
Fibroblast - Choroid Plexus, donor2	11572-120E6	21.57	0.86	0.00	0.86
Fibroblast - Choroid Plexus, donor3	11653-122E6	33.69	1.46	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	36.44	0.92	0.46	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	28.32	1.02	0.17	0.68
Fibroblast - Dermal, donor1	11269-116G9	21.37	0.70	0.00	0.70
Fibroblast - Dermal, donor2	11346-117G5	27.36	0.94	0.00	0.94
Fibroblast - Dermal, donor3	11418-118F5	21.88	0.73	0.48	0.12
Fibroblast - Dermal, donor4	11450-119A1	19.10	0.68	0.11	0.00
Fibroblast - Dermal, donor5	11454-119A5	22.68	1.22	0.70	0.17
Fibroblast - Dermal, donor6	11458-119A9	25.99	1.95	0.00	0.00
Fibroblast - Gingival, donor1	11237-116D4	26.03	1.04	0.42	0.21
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	23.84	0.52	0.26	0.26
Fibroblast - Gingival, donor2	11318-117D4	26.09	1.58	0.00	0.00
Fibroblast - Gingival, donor3	11394-118C8	27.46	0.97	0.19	0.10
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	41.56	2.08	1.04	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	34.54	0.70	0.53	0.35
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	31.18	1.40	0.47	0.31
Fibroblast - Gingival, donor6 (control)	11922-125H5	20.83	1.62	0.27	0.54
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	34.23	1.41	1.41	1.41
Fibroblast - Gingival, donor7 (control)	11924-125H7	29.54	1.17	1.02	0.58
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	20.59	1.23	0.14	0.41
Fibroblast - Gingival, donor8 (control)	11926-125H9	24.57	1.86	0.33	0.00
Fibroblast - Gingival, donor9 (control)	11927-125I1	25.53	1.03	0.15	0.44
Fibroblast - Lung, donor1	11270-116H1	17.67	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	19.40	1.49	0.00	1.49
Fibroblast - Lung, donor3	11419-118F6	28.70	1.06	0.42	0.21
Fibroblast - Lymphatic, donor1	11506-119G3	57.48	4.17	1.67	0.83
Fibroblast - Lymphatic, donor2	11586-120G2	33.57	4.20	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	23.23	1.40	0.00	0.28
Fibroblast - Mammary, donor1	11540-120B1	74.70	2.44	0.81	0.00
Fibroblast - Mammary, donor2	11620-122A9	51.92	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	59.56	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	24.63	2.33	0.19	0.00
Fibroblast - Periodontal Ligament, donor2	11319-117D5	34.89	1.97	0.15	0.00
Fibroblast - Periodontal Ligament, donor3	11395-118C9	41.61	1.84	0.61	0.92
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	27.10	1.14	1.14	0.38
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	40.50	1.62	0.27	0.27
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	44.53	1.28	0.81	0.46
Fibroblast - Pulmonary Artery, donor1	11250-116E8	47.53	1.99	0.44	0.55
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	62.79	3.66	1.02	0.81
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	28.06	1.34	0.67	0.67
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	22.14	0.79	0.00	0.40
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	12.90	1.19	0.20	0.20
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	33.04	1.07	0.18	0.36
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	31.73	0.20	0.39	0.20
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	10.53	0.60	0.00	0.30
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	28.61	1.94	0.22	0.43
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	10.12	0.25	0.00	0.00
Fibroblast - skin normal, donor1	11553-120C5	38.07	0.98	0.33	0.66
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	12.63	0.80	0.20	0.40
Fibroblast - skin normal, donor2	11561-120D4	35.97	1.71	0.80	0.50
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	8.76	1.21	0.30	0.00
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	31.32	1.24	0.00	0.33
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	25.98	0.51	0.00	0.34
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	9.85	0.99	0.33	0.33
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	40.05	2.88	0.32	0.53
Fibroblast - skin walker warburg, donor1	11554-120C6	35.93	2.02	0.51	0.00
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	24.78	1.10	0.94	0.63
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	22.16	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	76.69	11.33	2.61	1.74
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	63.45	4.16	3.64	6.24
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	90.04	5.47	4.42	3.64
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	79.46	5.62	3.32	3.07
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	29.09	3.06	0.77	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	33.82	0.00	0.64	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	35.66	2.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	43.85	0.55	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	33.11	5.02	0.68	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	41.41	1.39	0.20	0.20
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	38.06	0.26	0.26	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	26.74	5.22	0.33	0.98
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	37.15	3.10	0.44	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	40.70	1.70	0.14	0.28
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	42.36	1.11	0.37	0.99
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	43.25	2.95	0.81	0.81
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	37.54	1.12	0.25	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	35.30	0.69	0.00	0.42
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	30.90	0.41	0.00	0.20
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	33.31	1.83	0.23	0.46
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	33.26	1.12	0.37	0.25
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	37.16	0.44	0.00	0.44
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	42.25	2.36	0.89	0.30
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	29.73	0.79	0.16	0.48
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	43.34	2.23	0.89	0.22
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	31.66	1.41	0.60	0.40
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	29.18	1.70	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	51.34	2.13	1.15	0.53
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	62.64	3.75	0.62	0.42
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	45.94	3.07	0.34	0.34
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	30.76	1.44	0.55	0.11
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	45.51	1.83	0.92	0.58
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	40.84	3.06	0.41	0.20
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	31.98	2.06	0.41	0.21
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	34.13	1.61	0.00	0.12
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	39.69	2.33	0.17	0.17
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	33.95	3.31	0.22	0.44
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	39.36	1.97	0.25	0.37
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	40.85	2.11	0.16	0.49
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	37.84	3.21	0.00	0.32
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	35.25	1.42	0.38	0.09
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	42.07	2.06	1.11	0.32
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	37.40	2.74	0.30	0.30
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	35.12	2.30	0.21	0.21
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	43.25	3.73	0.88	0.22
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	37.03	3.09	0.56	0.56
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	30.92	2.13	0.46	0.28
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	37.44	1.34	0.00	1.07
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	41.62	2.14	0.31	0.61
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	38.08	2.98	0.52	0.39
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	43.10	4.07	0.27	0.81
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	38.53	2.40	0.74	0.18
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	33.34	1.32	0.22	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	59.50	3.97	0.00	2.98
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	37.59	1.71	0.66	0.13
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	33.29	2.02	0.20	0.40
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	167.49	5.85	1.78	2.29
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	42.20	1.00	1.19	0.40
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	37.75	1.08	0.46	0.15
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	40.92	1.64	0.41	0.61
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	39.43	1.88	0.94	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	37.01	1.98	0.28	0.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	28.13	0.92	1.84	0.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	39.60	2.47	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	28.62	0.77	0.77	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	27.28	3.21	1.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	31.30	1.74	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	24.74	2.28	0.65	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	26.36	1.24	1.24	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	19.99	3.33	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	26.57	2.52	0.28	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	25.49	1.31	0.33	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	25.17	0.84	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	25.13	0.64	0.32	0.64
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	28.53	1.02	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	18.79	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	28.06	1.15	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	33.15	0.89	0.00	0.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	32.19	0.00	1.69	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	31.07	1.66	0.41	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	20.94	1.15	0.23	0.92
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	15.81	5.27	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	26.14	2.69	0.38	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	27.71	1.30	0.98	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	26.08	2.01	0.00	0.67
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	25.04	2.31	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	31.15	1.71	0.68	0.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	14.91	2.48	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	33.03	0.94	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	20.52	3.02	0.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	21.36	2.03	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	21.14	1.20	0.40	0.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	41.44	1.48	0.49	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	31.87	0.00	0.00	1.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	33.84	2.33	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	42.57	1.32	0.00	0.44
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	20.34	1.70	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	19.10	1.19	0.00	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	16.50	0.97	0.49	0.49
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	39.95	0.00	0.00	2.28
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	22.45	2.08	0.00	0.42
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	47.23	0.00	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	30.13	0.95	0.00	1.59
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	23.81	0.84	0.00	0.42
Hep-2 cells mock treated, biol_rep1	11898-125E8	72.06	5.80	1.28	0.46
Hep-2 cells mock treated, biol_rep2	11899-125E9	70.22	9.62	2.36	0.68
Hep-2 cells mock treated, biol_rep3	11900-125F1	65.52	5.46	1.82	0.68
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	70.50	6.12	1.75	0.66
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	69.20	7.09	1.07	0.43
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	66.31	6.24	1.29	0.65
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	76.22	8.59	1.62	0.50
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	62.44	7.03	0.86	0.69
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	66.00	5.77	0.96	0.64
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	34.14	0.00	0.56	0.56
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	41.55	0.43	0.43	1.30
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	23.79	0.00	2.64	2.64
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	47.97	3.17	0.35	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	26.15	2.18	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	34.79	2.10	0.35	0.00
Hepatocyte, donor1	11523-119I2	32.69	2.42	0.00	1.21
Hepatocyte, donor2	11603-120I1	48.48	3.23	0.00	1.08
Hepatocyte, donor3	11684-122I1	47.24	5.52	0.00	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	28.72	1.96	0.65	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	64.14	3.67	0.87	0.52
Iris Pigment Epithelial Cells, donor1	11530-119I9	30.19	1.78	0.14	0.27
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	41.39	3.18	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	60.08	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	27.08	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	41.53	1.38	1.38	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	47.55	5.01	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	11.87	11.87	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	41.01	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	22.85	4.57	4.57	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	48.73	3.25	1.62	1.62
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	53.35	5.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	29.04	0.00	3.63	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	48.97	2.65	0.00	2.65
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	37.69	3.33	1.11	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	68.10	10.48	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	32.75	9.45	1.26	0.63
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	40.21	3.09	0.00	1.55
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	29.27	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	45.22	0.65	0.65	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	30.59	1.61	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	11.95	11.95	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	56.23	2.44	2.44	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	48.28	2.52	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	86.23	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	35.36	2.41	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	44.32	0.92	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	30.16	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	55.70	4.72	0.94	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	44.44	2.72	0.91	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	14.74	0.00	14.74	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	43.04	2.15	1.08	2.15
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	38.11	1.27	1.27	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	32.86	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	55.48	2.55	0.64	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	32.81	1.82	1.82	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	63.22	15.80	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	34.28	4.28	0.71	0.71
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	43.14	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	20.85	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	50.00	0.93	0.31	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	43.90	1.76	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	34.57	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	50.76	2.78	0.00	0.70
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	57.54	6.64	0.00	2.21
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	42.15	3.24	3.24	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	42.72	4.36	0.00	0.87
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	33.75	0.00	4.50	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	38.33	13.94	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	59.74	4.27	2.13	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	51.26	4.16	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	37.04	2.85	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	55.23	0.92	0.00	0.92
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	42.35	3.03	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	74.50	0.00	6.21	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	57.10	0.00	2.11	0.00
Keratinocyte - epidermal, donor1	11272-116H3	79.72	6.04	4.57	5.06
Keratinocyte - epidermal, donor2	11349-117G8	52.71	4.10	2.34	3.51
Keratinocyte - epidermal, donor3	11421-118F8	86.33	5.02	4.64	2.18
Keratinocyte - oral, donor1	11251-116E9	75.94	3.41	1.36	0.68
Keratocytes, donor1	11527-119I6	49.86	1.38	1.03	0.34
Keratocytes, donor2	11607-120I5	31.64	2.34	1.17	0.00
Keratocytes, donor3	11688-122I5	24.30	0.59	0.00	0.20
Krukenberg tumor cell line:HSKTC	10687-109F3	68.14	17.58	6.59	0.00
Lens Epithelial Cells, donor1	11529-119I8	22.65	2.16	0.00	1.08
Lens Epithelial Cells, donor2	11609-120I7	35.29	1.27	0.46	0.00
Lens Epithelial Cells, donor3	11690-122I7	28.76	1.31	0.10	0.30
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	48.74	0.71	1.54	0.59
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	31.26	1.40	0.56	1.12
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	37.62	0.94	0.94	0.94
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	24.73	0.54	0.54	0.54
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	35.61	1.26	0.95	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	35.58	0.75	0.65	1.19
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	27.91	1.23	0.41	0.82
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	28.06	1.26	0.51	0.51
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	31.39	0.84	0.99	0.56
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	26.50	0.40	0.79	1.19
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	35.87	0.58	0.97	0.78
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	31.48	0.37	0.74	0.56
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	28.57	0.00	0.70	0.35
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	39.36	0.72	0.24	0.95
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	32.69	0.96	1.10	0.55
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	37.88	0.00	1.54	0.92
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	27.43	0.62	0.62	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	35.68	0.37	0.91	0.73
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	33.57	0.99	1.65	0.66
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	31.92	1.46	0.59	0.29
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	29.87	0.50	1.49	0.75
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	29.10	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	26.66	0.54	0.54	0.81
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	29.37	0.30	1.36	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	23.33	0.52	0.00	2.59
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	33.71	0.63	0.84	0.63
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	33.83	0.75	1.20	0.75
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	22.70	1.38	0.69	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	33.30	0.94	1.13	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	28.63	0.64	1.48	0.74
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	27.62	0.48	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	27.12	0.00	0.99	0.66
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	33.20	0.74	0.99	0.62
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	29.62	0.00	0.37	1.48
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	32.37	1.24	0.25	0.49
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	27.91	0.41	0.55	0.69
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	27.66	1.29	0.32	1.29
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	35.30	0.91	2.74	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	32.75	0.98	0.98	1.26
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	27.02	0.36	0.36	0.36
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	26.18	0.48	0.48	0.48
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	29.41	0.62	1.09	1.24
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	40.82	0.00	1.07	0.36
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	30.71	0.65	1.63	0.98
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	34.14	0.24	0.94	0.47
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	52.22	0.87	1.61	1.11
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	32.78	0.26	1.28	0.26
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	31.63	0.60	0.30	0.30
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	101.97	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	76.71	6.90	0.00	1.53
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	51.96	2.97	0.00	1.48
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	55.85	4.23	0.00	1.27
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	71.04	3.52	0.70	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	56.04	2.80	0.00	1.87
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	45.34	4.64	0.52	0.52
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	58.28	2.38	0.00	1.19
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	73.74	5.88	1.13	0.90
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	46.82	3.20	1.16	0.87
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	56.27	2.70	1.35	0.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	75.74	6.23	0.54	1.76
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	55.97	5.14	0.00	1.03
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	64.93	4.94	1.41	0.35
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	55.30	4.00	0.67	0.67
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	52.47	6.11	1.02	1.53
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	72.57	5.07	0.00	0.53
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	68.21	4.16	1.32	0.57
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	52.77	3.07	0.61	1.23
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	74.20	2.45	0.82	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	67.89	4.58	1.04	1.25
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	52.69	3.92	1.40	1.68
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	79.34	5.15	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	71.12	6.68	1.74	0.29
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	58.29	3.59	0.30	0.30
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	60.30	4.43	1.11	1.66
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	67.87	5.30	0.71	0.71
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	50.15	3.32	1.11	1.84
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	56.41	6.91	1.15	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	74.45	6.52	0.77	1.15
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	43.59	4.53	0.57	0.57
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	67.28	2.46	2.46	1.64
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	66.88	8.13	1.81	1.81
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	53.86	2.87	0.72	0.72
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	80.67	5.98	2.24	0.75
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	67.63	5.57	0.74	1.49
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	56.86	5.17	1.72	0.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	73.64	9.42	0.86	2.57
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	64.97	2.33	0.67	0.67
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	64.55	5.43	0.00	1.81
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	76.79	1.42	1.42	0.71
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	64.28	6.19	1.37	1.03
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	53.14	4.29	1.61	1.61
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	59.93	4.04	0.67	2.02
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	68.16	7.41	1.48	0.74
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	74.43	6.98	1.16	1.16
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	60.29	2.12	1.06	1.06
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	64.02	5.20	1.20	1.20
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	43.61	4.36	0.00	2.18
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	81.25	6.13	1.53	0.77
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	58.21	6.41	1.48	2.96
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	42.34	3.76	0.94	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	93.02	8.05	2.01	1.51
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	59.93	7.21	1.35	1.35
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	27.54	1.72	1.72	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	74.82	8.91	0.89	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	61.78	4.30	1.56	3.52
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	43.54	5.28	0.00	0.66
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	72.65	2.08	0.00	0.52
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	71.32	5.25	0.44	0.88
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	54.23	2.80	1.12	1.12
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	73.31	6.18	0.88	3.09
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	70.20	3.09	0.77	0.39
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	49.12	6.08	1.01	0.51
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	55.27	7.21	1.44	0.96
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	66.39	5.17	0.80	1.59
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	42.53	3.04	1.82	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	40.81	5.53	0.69	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	63.84	3.42	0.76	1.52
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	45.44	4.13	1.55	1.55
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	42.93	5.44	1.21	1.21
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	60.84	6.34	1.90	0.63
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	49.04	2.67	1.60	1.60
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	33.33	1.72	0.57	0.57
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	50.39	6.17	2.06	1.54
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	47.39	5.66	0.00	0.71
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	43.70	5.67	2.27	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	72.80	4.16	2.50	0.83
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	45.42	1.57	3.13	1.57
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	49.27	2.92	1.25	1.67
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	61.80	6.04	2.32	2.32
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	50.18	6.02	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	61.48	5.88	0.53	1.60
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	75.16	5.66	1.21	2.02
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	57.82	2.75	0.92	0.92
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	50.68	3.56	1.78	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	67.81	3.99	1.71	0.57
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	59.82	4.60	0.77	0.77
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	47.06	2.74	0.55	1.09
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	72.61	6.68	4.01	0.45
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	84.49	3.12	1.82	0.52
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	51.06	5.30	0.00	0.66
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	56.12	2.08	4.16	0.00
Macrophage - monocyte derived, donor1	11232-116C8	98.23	4.10	3.65	1.60
Macrophage - monocyte derived, donor2	11313-117C8	72.85	3.49	1.28	0.18
Macrophage - monocyte derived, donor3	11389-118C3	80.48	2.88	2.49	0.52
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	60.54	2.12	4.78	1.06
Mallassez-derived cells, donor2	11929-125I3	65.12	2.54	1.58	3.49
Mallassez-derived cells, donor3	11930-125I4	60.74	2.50	2.08	2.22
Mammary Epithelial Cell, donor1	11273-116H4	55.50	3.09	1.69	0.70
Mammary Epithelial Cell, donor2	11350-117G9	48.93	4.34	1.16	0.29
Mammary Epithelial Cell, donor3	11422-118F9	43.40	1.25	1.00	1.25
Mast cell - stimulated, donor1	11487-119E2	70.51	2.03	0.00	0.00
Mast cell, donor1	11563-120D6	48.12	0.76	0.22	0.22
Mast cell, donor2	11565-120D8	46.66	0.30	0.00	0.30
Mast cell, donor3	11566-120D9	63.94	0.68	0.23	0.00
Mast cell, donor4	11567-120E1	51.24	1.24	0.53	0.18
Mast cell, expanded and stimulated, donor5	11940-126A5	35.04	0.44	0.44	0.33
Mast cell, expanded and stimulated, donor8	11942-126A7	19.26	0.00	0.58	1.17
Mast cell, expanded, donor5	11939-126A4	38.20	0.57	0.46	0.34
Mast cell, expanded, donor8	11941-126A6	33.64	0.50	0.33	1.00
Melanocyte - dark, donor1	11502-119F8	56.12	1.09	1.39	1.19
Melanocyte - dark, donor2	11582-120F7	19.73	0.69	0.35	0.69
Melanocyte - dark, donor3	11663-122F7	119.45	4.49	1.45	0.22
Melanocyte - light, donor1	11274-116H5	51.72	3.53	0.71	0.94
Melanocyte - light, donor2	11351-117H1	51.18	4.09	0.00	1.36
Melanocyte - light, donor3	11423-118G1	41.63	1.73	0.87	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	61.85	2.50	0.62	0.00
Melanocyte, donor2 (MC+2)	12739-135I3	49.75	2.96	1.08	0.54
Melanocyte, donor3 (MC+3)	12837-137B2	82.50	3.21	1.61	0.27
Meningeal Cells, donor1	11493-119E8	35.61	2.98	0.62	0.12
Meningeal Cells, donor2	11573-120E7	36.97	2.64	0.88	0.00
Meningeal Cells, donor3	11654-122E7	37.25	1.55	1.06	0.57
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	34.79	1.14	0.29	0.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	42.97	1.61	1.11	0.91
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	9.20	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	28.78	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	26.55	0.72	0.00	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	30.71	1.27	0.85	0.42
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	21.61	0.00	1.01	0.50
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	48.35	2.42	0.88	0.22
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	37.99	4.38	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	41.53	3.48	0.20	0.00
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	22.02	0.69	0.14	0.42
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	42.75	2.23	0.37	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	48.55	1.18	0.13	0.53
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	43.32	0.59	0.59	1.19
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	23.36	0.00	0.00	2.34
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	34.58	1.92	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	41.12	0.71	0.35	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	47.85	2.19	0.31	0.31
Mesenchymal stem cells - umbilical, donor0	11214-116A8	37.74	0.00	0.00	0.00
Mesothelial Cells, donor1	11247-116E5	40.57	1.33	0.27	0.53
Mesothelial Cells, donor2	12156-128G5	59.56	0.00	2.50	1.50
Mesothelial Cells, donor3	11402-118D7	36.57	1.16	0.29	0.72
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	81.02	0.00	6.75	1.35
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	69.70	1.97	3.45	0.25
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	57.12	2.65	2.36	0.29
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	34.57	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	62.92	2.48	3.72	0.31
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	57.25	1.87	2.28	0.41
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	39.37	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	82.59	2.50	2.50	0.75
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	59.58	1.40	0.47	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	19.47	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	66.25	1.63	3.86	0.81
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	54.64	2.38	1.98	0.79
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	25.65	0.00	8.55	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	39.82	0.88	0.88	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	52.81	1.90	3.04	0.38
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	28.95	0.00	1.32	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	49.02	2.12	3.61	0.64
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	30.39	0.00	1.84	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	49.18	0.89	2.09	1.19
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	31.86	3.35	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	41.65	2.26	2.76	0.50
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	40.40	1.90	0.95	0.48
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	28.20	1.11	1.66	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	44.44	2.30	2.07	0.23
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	44.38	1.68	1.68	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	40.97	3.06	1.83	0.41
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	57.50	1.50	2.36	0.64
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	34.90	1.78	1.33	0.44
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	20.64	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	33.51	1.31	1.53	0.88
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	24.84	2.53	1.52	0.51
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	23.20	0.00	0.00	1.66
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	37.78	0.82	1.09	0.27
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	41.47	1.76	0.88	1.18
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	19.63	1.09	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	35.56	0.96	0.48	0.96
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	29.62	0.40	1.60	0.40
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	27.42	1.37	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	32.04	2.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	26.50	2.04	2.04	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	28.90	1.75	1.75	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	23.18	1.10	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	19.85	1.28	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	31.73	0.50	0.99	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	27.84	0.70	0.70	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	11.05	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	39.66	2.74	1.37	0.34
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	24.07	0.88	0.44	0.44
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	18.46	0.36	0.00	0.36
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	40.96	1.12	1.12	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	28.68	1.25	0.42	0.83
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	25.64	0.58	1.17	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	33.79	1.81	0.90	0.30
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	34.23	0.83	0.83	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	21.66	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	33.25	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	34.72	1.71	0.57	0.57
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	38.28	1.52	0.83	0.14
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	31.62	2.07	0.26	0.52
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	43.76	1.72	0.43	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	24.14	1.27	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	28.82	0.27	0.80	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	84.11	5.69	1.50	1.20
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	45.20	1.55	0.85	0.57
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	28.67	1.59	0.32	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	56.17	2.21	1.99	0.44
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	37.16	1.52	0.76	0.38
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	42.05	2.27	1.70	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	60.71	1.23	1.47	0.74
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	44.97	4.56	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	47.34	1.47	0.00	0.29
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	79.58	3.17	3.17	1.44
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	83.67	3.30	2.89	0.82
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	51.22	3.57	0.60	0.89
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	86.64	7.53	3.77	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	87.33	1.78	5.35	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	92.99	3.61	2.96	0.99
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	59.96	7.36	4.21	1.05
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	84.02	3.36	4.35	0.59
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	78.23	3.73	3.73	0.93
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	77.36	3.38	6.01	0.38
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	62.86	3.20	4.26	0.80
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	67.18	2.38	4.64	0.57
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	72.20	2.95	3.68	0.74
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	86.11	2.56	3.66	1.10
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	57.56	3.11	10.89	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	84.98	2.14	5.88	1.07
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	77.28	3.86	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	102.00	3.03	5.05	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	80.95	4.22	2.11	0.42
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	85.80	2.72	8.17	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	29.25	0.64	3.81	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	53.45	0.00	7.29	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	96.67	6.04	10.57	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	114.20	0.00	5.71	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	97.87	3.26	3.26	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	28.51	4.75	9.50	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	163.14	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	46.53	1.29	1.29	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	21.43	0.52	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	28.03	1.33	0.67	0.67
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	28.80	1.25	0.42	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	19.20	0.76	0.00	0.19
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	33.51	1.60	0.00	1.60
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	22.44	0.00	1.36	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	12.86	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	18.00	1.26	0.00	0.84
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	27.20	1.86	0.23	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	17.83	1.89	0.81	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	17.03	0.42	0.00	0.21
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	44.54	11.13	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	15.88	0.50	0.00	0.50
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	14.35	1.08	0.27	0.81
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	17.23	0.91	0.00	0.91
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	18.13	0.65	0.33	0.00
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	16.22	0.73	0.55	0.00
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	13.79	0.00	0.00	1.06
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	10.21	1.80	0.00	0.60
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	9.19	0.66	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	22.28	0.65	0.49	0.00
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	18.87	0.88	0.00	0.18
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	26.72	2.81	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	21.15	0.46	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	25.39	1.29	0.64	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	18.97	0.34	0.34	0.34
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	15.17	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	18.49	1.34	0.00	0.22
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	23.29	3.39	1.27	0.42
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	15.19	0.47	0.24	0.24
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	28.33	1.72	0.86	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	27.08	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	23.33	1.33	0.33	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	21.64	1.80	0.45	0.45
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	22.62	1.98	0.40	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	26.93	1.86	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	28.38	0.76	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	34.54	1.96	0.65	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	25.28	0.87	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	23.97	0.45	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	29.98	0.88	1.76	0.88
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	19.95	1.99	0.66	1.33
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	26.79	0.99	0.99	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	27.56	1.15	0.00	0.77
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	22.68	0.60	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	20.78	0.88	0.66	0.00
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	29.14	3.39	1.36	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	10.22	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	29.26	0.61	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	33.99	2.52	0.31	0.63
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	27.54	2.12	0.61	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	39.56	1.58	0.79	0.79
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	15.87	2.27	0.00	1.13
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	5.06	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	38.26	2.86	0.12	0.50
Myoblast, donor2	11322-117D8	22.25	2.30	0.58	0.77
Myoblast, donor3	11398-118D3	35.48	1.51	1.01	0.34
NK T cell leukemia cell line:KHYG-1	10777-110G3	41.74	2.19	0.88	0.44
Natural Killer Cells, donor1	11230-116C6	53.20	1.23	3.38	0.62
Natural Killer Cells, donor2	11311-117C6	53.07	1.21	2.11	1.51
Natural Killer Cells, donor3	11387-118C1	63.31	2.02	2.02	0.18
Neural stem cells, donor1	11275-116H6	34.12	0.36	0.36	0.00
Neural stem cells, donor2	11352-117H2	40.44	1.93	0.00	0.00
Neurons, donor1	11494-119E9	25.03	3.41	1.14	0.00
Neurons, donor2	11574-120E8	29.28	1.76	0.22	0.00
Neurons, donor3	11655-122E8	22.20	2.47	0.82	0.00
Neutrophils, donor1	11233-116C9	266.34	21.34	21.34	2.78
Neutrophils, donor2	11314-117C9	211.62	14.49	23.19	2.90
Neutrophils, donor3	11390-118C4	411.71	39.09	31.76	8.55
Nucleus Pulposus Cell, donor1	11252-116F1	29.45	1.42	0.12	0.59
Nucleus Pulposus Cell, donor2	11409-118E5	16.61	0.98	0.00	0.33
Nucleus Pulposus Cell, donor3	11462-119B4	16.04	0.80	0.00	0.20
Olfactory epithelial cells, donor1	11933-125I7	20.79	0.83	0.28	0.41
Olfactory epithelial cells, donor2	11934-125I8	23.30	0.87	0.14	0.14
Olfactory epithelial cells, donor3	11935-125I9	21.68	0.57	0.11	0.45
Olfactory epithelial cells, donor4	11936-126A1	26.69	1.07	0.39	0.78
Oligodendrocyte - precursors, donor1	11496-119F2	56.57	3.01	1.20	1.20
Osteoblast - differentiated, donor1	11276-116H7	34.03	1.49	0.00	1.06
Osteoblast - differentiated, donor2	11353-117H3	49.15	0.00	0.00	1.14
Osteoblast - differentiated, donor3	11425-118G3	22.35	0.62	0.62	0.62
Osteoblast, donor1	11277-116H8	18.96	1.17	0.59	0.39
Osteoblast, donor2	11354-117H4	25.28	1.40	0.70	0.70
Osteoblast, donor3	11426-118G4	40.88	2.31	0.18	0.53
Pancreatic stromal cells, donor1	11249-116E7	25.35	1.10	0.25	0.08
Pericytes, donor1	11491-119E6	33.49	0.56	0.22	0.22
Pericytes, donor2	11571-120E5	30.33	2.26	0.45	0.00
Pericytes, donor3	11652-122E5	48.22	2.24	1.02	0.41
Perineurial Cells, donor1	11499-119F5	42.95	1.36	0.45	0.57
Perineurial Cells, donor2	11579-120F4	41.50	1.56	0.74	0.74
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	72.04	1.91	1.59	0.32
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	61.95	2.45	3.43	0.73
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	60.95	2.72	2.33	0.65
Placental Epithelial Cells, donor1	11278-116H9	60.99	6.70	0.96	0.48
Placental Epithelial Cells, donor2	11355-117H5	47.68	4.44	2.22	1.11
Placental Epithelial Cells, donor3	11427-118G5	33.96	1.37	0.39	0.39
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	56.33	2.22	1.58	0.95
Preadipocyte - breast, donor1	11467-119B9	40.14	3.38	1.31	0.75
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	12.79	0.52	0.26	1.17
Preadipocyte - breast, donor2	11328-117E5	52.23	1.35	0.90	0.68
Preadipocyte - omental, donor1	11468-119C1	43.90	2.56	0.85	1.70
Preadipocyte - omental, donor2	11329-117E6	61.54	2.18	0.44	1.31
Preadipocyte - omental, donor3	11403-118D8	64.18	2.01	1.00	1.00
Preadipocyte - perirenal, donor1	11469-119C2	38.39	3.94	0.98	1.97
Preadipocyte - subcutaneous, donor1	11279-116I1	39.93	2.46	1.54	0.31
Preadipocyte - subcutaneous, donor2	11356-117H6	37.72	2.12	0.89	0.89
Preadipocyte - subcutaneous, donor3	11428-118G6	30.31	0.68	0.17	0.00
Preadipocyte - visceral, donor1	11280-116I2	34.93	1.12	0.84	0.19
Preadipocyte - visceral, donor2	11357-117H7	40.50	0.46	0.00	0.46
Preadipocyte - visceral, donor3	11429-118G7	28.63	0.84	0.21	0.21
Prostate Epithelial Cells (polarized), donor1	11253-116F2	37.71	3.92	0.30	0.45
Prostate Epithelial Cells, donor2	11331-117E8	35.48	2.44	0.95	1.76
Prostate Epithelial Cells, donor3	11404-118D9	64.36	8.82	1.84	2.20
Prostate Stromal Cells, donor1	11254-116F3	41.46	1.82	0.46	0.46
Prostate Stromal Cells, donor2	11332-117E9	35.14	1.26	0.54	0.18
Prostate Stromal Cells, donor3	11405-118E1	27.63	1.15	0.52	0.21
Renal Cortical Epithelial Cells, donor1	11516-119H4	55.84	1.09	0.36	0.36
Renal Cortical Epithelial Cells, donor2	11596-120H3	42.14	1.80	0.14	0.35
Renal Epithelial Cells, donor1	11517-119H5	37.54	1.52	0.51	0.00
Renal Epithelial Cells, donor2	11597-120H4	28.45	1.42	1.42	0.00
Renal Epithelial Cells, donor3	11678-122H4	41.29	0.53	0.95	0.32
Renal Glomerular Endothelial Cells, donor1	11514-119H2	32.00	1.36	0.68	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	27.49	0.81	0.94	0.13
Renal Glomerular Endothelial Cells, donor3	11675-122H1	25.98	2.00	0.44	0.22
Renal Glomerular Endothelial Cells, donor4	11783-124B1	39.26	0.00	0.00	0.67
Renal Mesangial Cells, donor1	11518-119H6	41.38	1.76	0.22	0.22
Renal Mesangial Cells, donor2	11598-120H5	37.62	0.00	0.00	0.00
Renal Mesangial Cells, donor3	11679-122H5	29.41	0.55	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	64.15	3.22	1.61	0.54
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	33.74	2.11	0.00	0.84
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	33.36	0.77	0.77	0.00
Retinal Pigment Epithelial Cells, donor0	11215-116A9	38.37	0.78	0.26	0.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	36.67	0.85	0.00	0.57
Retinal Pigment Epithelial Cells, donor2	11608-120I6	22.64	3.09	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	22.58	2.01	0.75	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	91.54	10.69	0.27	1.74
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	17.87	0.00	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	12.11	0.00	0.55	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	17.40	1.16	0.58	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	29.39	1.95	0.52	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	38.33	1.59	0.70	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	43.39	2.12	1.23	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	43.17	2.85	0.62	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	45.10	3.73	1.17	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	39.75	1.62	1.39	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	28.20	1.92	0.27	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	34.34	2.57	0.91	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	41.57	2.69	1.08	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	30.27	2.15	0.57	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	36.06	2.04	1.18	0.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	33.63	2.21	0.89	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	26.57	1.72	0.57	0.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	42.39	3.07	0.65	0.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	47.35	3.01	0.94	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	28.27	1.19	0.80	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	40.59	3.02	0.58	0.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	44.88	2.10	1.34	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	30.22	2.14	0.64	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	35.88	3.36	1.68	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	35.38	2.56	1.54	0.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	29.72	1.46	0.73	0.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	38.75	2.58	0.61	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	43.25	2.82	0.81	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	29.25	1.18	0.71	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	38.69	2.18	0.60	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	38.12	0.94	0.23	0.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	30.27	0.41	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	34.73	2.88	0.66	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	33.84	1.46	0.42	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	33.38	3.10	1.08	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	40.36	2.72	0.34	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	41.07	1.74	0.96	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	29.23	2.75	1.38	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	39.78	2.47	0.69	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	38.58	2.30	0.82	0.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	25.22	1.53	0.17	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	44.54	2.07	0.59	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	33.32	1.87	1.07	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	27.79	1.80	0.28	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	40.00	2.38	0.48	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	47.16	2.42	1.21	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	34.28	2.35	0.94	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	37.03	2.10	1.75	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	29.62	1.81	0.60	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	36.47	2.94	1.35	0.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	33.77	1.89	0.58	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	35.90	3.04	1.22	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	33.15	0.30	0.90	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	38.23	5.20	1.36	0.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	42.24	2.70	0.60	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	27.63	2.72	0.47	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	38.42	2.35	0.85	0.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	37.26	2.40	1.20	0.00
Schwann Cells, donor1	11498-119F4	34.79	1.69	0.19	0.38
Schwann Cells, donor2	11578-120F3	13.61	0.00	0.00	3.40
Schwann Cells, donor3	11659-122F3	26.51	1.97	0.00	0.22
Sebocyte, donor1	11220-116B5	130.37	8.76	10.96	7.12
Sebocyte, donor2	11301-117B5	66.18	4.14	1.84	2.76
Sebocyte, donor3	11378-118B1	63.28	6.39	2.68	1.65
Sertoli Cells, donor1	11255-116F4	51.35	1.66	0.00	1.66
Sertoli Cells, donor2	11333-117F1	28.24	2.82	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	26.75	1.58	0.70	0.35
Skeletal Muscle Cells, donor2	11358-117H8	31.81	0.00	2.17	0.00
Skeletal Muscle Cells, donor3	11430-118G8	31.77	2.51	0.84	0.00
Skeletal Muscle Cells, donor4	11451-119A2	27.49	1.10	0.16	0.16
Skeletal Muscle Cells, donor5	11455-119A6	22.30	0.89	0.30	0.00
Skeletal Muscle Cells, donor6	11459-119B1	28.63	0.92	0.46	0.31
Skeletal Muscle Satellite Cells, donor1	11240-116D7	29.74	1.26	0.38	0.25
Skeletal Muscle Satellite Cells, donor2	11321-117D7	25.26	0.86	0.14	0.57
Skeletal Muscle Satellite Cells, donor3	11397-118D2	36.71	2.08	0.99	0.30
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	34.63	3.03	2.53	0.34
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	25.33	1.45	0.72	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	16.37	0.69	0.41	0.41
Skin - palm, donor1	10286-104F7	40.29	10.74	2.69	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	48.87	3.17	1.87	2.74
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	28.63	0.82	0.00	2.45
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	54.40	3.51	1.69	2.34
Small Airway Epithelial Cells, donor1	11256-116F5	68.81	4.59	4.45	3.61
Small Airway Epithelial Cells, donor2	11334-117F2	56.83	2.39	3.80	4.08
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	47.15	3.17	2.11	1.69
Small Airway Epithelial Cells, donor3	11406-118E2	68.20	5.70	2.85	2.92
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	52.46	4.32	0.31	0.31
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	12.45	2.00	0.22	1.11
Smooth Muscle Cells - Aortic, donor0	11210-116A4	56.43	1.18	1.18	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	39.78	1.77	0.44	0.66
Smooth Muscle Cells - Aortic, donor2	11360-117I1	43.32	3.54	1.58	1.18
Smooth Muscle Cells - Aortic, donor3	11432-118H1	51.76	2.32	1.55	0.77
Smooth Muscle Cells - Bladder, donor1	11519-119H7	22.02	0.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	48.31	2.40	2.13	0.93
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	52.09	1.11	0.89	1.11
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	53.39	2.94	1.66	0.77
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	25.40	1.63	0.00	0.65
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	48.73	1.77	0.59	0.00
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	33.60	1.71	0.71	0.00
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	41.32	2.28	0.33	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	12.79	0.61	0.00	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	36.62	1.26	1.26	0.76
Smooth Muscle Cells - Carotid, donor2	11362-117I3	110.17	18.36	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	30.99	0.48	0.48	0.48
Smooth Muscle Cells - Colonic, donor1	11239-116D6	24.19	1.03	0.44	0.44
Smooth Muscle Cells - Colonic, donor2	11320-117D6	27.55	1.08	0.86	0.43
Smooth Muscle Cells - Colonic, donor3	11396-118D1	29.28	1.57	0.00	0.21
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	53.05	1.39	1.24	0.77
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	62.52	1.08	2.16	1.08
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	37.95	1.20	0.00	0.60
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	43.70	3.41	0.34	0.34
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	24.50	0.55	0.79	0.55
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	49.11	2.21	0.60	1.11
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	62.80	1.59	0.46	1.37
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	54.34	3.62	0.60	1.81
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	49.54	3.44	0.53	0.26
Smooth Muscle Cells - Prostate, donor1	11257-116F6	28.23	1.73	0.13	0.27
Smooth Muscle Cells - Prostate, donor2	11335-117F3	37.82	2.25	0.38	0.50
Smooth Muscle Cells - Prostate, donor3	11465-119B7	36.53	1.78	0.51	0.51
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	46.44	2.26	0.60	0.90
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	32.26	0.75	1.50	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	65.90	1.29	1.29	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	62.78	3.26	0.93	0.93
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	51.50	1.51	2.02	0.50
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	36.35	4.39	2.51	0.94
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	40.71	2.06	2.06	0.59
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	39.40	2.17	0.33	0.33
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	14.48	0.00	0.00	0.47
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	52.24	4.03	1.73	1.58
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	50.23	1.53	1.78	0.51
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	28.96	1.50	1.32	0.00
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	38.99	1.96	0.28	0.28
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	42.82	2.18	0.08	0.34
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	27.62	0.95	0.95	0.48
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	53.83	3.18	1.96	1.71
Smooth Muscle Cells - Uterine, donor1	11258-116F7	35.35	0.44	0.44	0.00
Smooth Muscle Cells - Uterine, donor3	11466-119B8	31.01	0.59	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	15.16	0.78	0.19	0.00
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	21.69	1.59	0.26	0.79
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	9.30	1.12	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	27.31	1.08	0.36	0.36
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	28.11	1.42	0.85	0.57
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	18.51	1.58	0.79	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	12.70	1.02	0.25	0.00
Smooth muscle cells - airway, control, donor2	11967-126D5	14.38	0.40	0.00	0.40
Smooth muscle cells - airway, control, donor3	11968-126D6	12.54	0.42	0.00	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	14.21	0.46	0.00	0.00
Synoviocyte, donor1	11291-117A4	34.34	1.01	0.17	0.34
Synoviocyte, donor2	11368-117I9	31.18	1.01	0.34	0.67
Synoviocyte, donor3	11440-118H9	18.77	0.89	0.00	0.45
Trabecular Meshwork Cells, donor1	11532-120A2	40.02	3.93	0.36	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	29.73	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	21.53	1.62	0.69	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	45.59	2.01	1.58	0.65
Tracheal Epithelial Cells, donor2	11369-118A1	52.96	5.03	2.71	0.77
Tracheal Epithelial Cells, donor3	11441-118I1	30.35	1.15	1.72	2.29
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	81.20	14.15	0.86	2.09
Urethra, donor2	10319-105A4	39.57	3.60	0.00	0.00
Urothelial Cells, donor1	11520-119H8	76.78	5.58	1.59	4.25
Urothelial Cells, donor2	11600-120H7	68.50	1.60	3.20	1.60
Urothelial Cells, donor3	11681-122H7	64.41	3.21	1.60	1.38
Urothelial cells, donor0	11216-116B1	93.62	2.90	2.23	0.89
Whole blood (ribopure), donor090309, donation1	12179-129A1	1421.87	814.15	36.48	36.48
Whole blood (ribopure), donor090309, donation2	12180-129A2	1581.15	867.77	44.32	45.75
Whole blood (ribopure), donor090309, donation3	12181-129A3	1219.81	594.85	14.37	37.65
Whole blood (ribopure), donor090325, donation1	12176-128I7	639.78	380.15	12.74	11.36
Whole blood (ribopure), donor090325, donation2	12177-128I8	644.36	370.11	13.94	11.04
Whole blood (ribopure), donor090612, donation1	12182-129A4	987.10	572.68	32.28	40.61
Whole blood (ribopure), donor090612, donation2	12183-129A5	1249.12	676.41	29.37	38.55
Whole blood (ribopure), donor090612, donation3	12184-129A6	1329.18	671.89	21.91	43.82
Wilms' tumor cell line:G-401	10809-111A8	34.05	1.97	0.62	0.37
Wilms' tumor cell line:HFWT	10597-108E3	17.60	0.00	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	72.06	6.70	0.84	0.00
achilles tendon, donor2	10292-104G4	31.00	2.07	0.00	2.07
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	75.72	1.53	2.04	0.25
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	59.90	2.55	0.70	0.00
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	56.39	1.66	0.47	0.12
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	84.36	2.72	2.18	0.00
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	46.38	0.84	0.84	0.00
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	47.37	0.85	1.90	0.42
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	39.47	1.09	1.36	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	33.05	1.76	2.20	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	31.85	0.41	0.41	0.00
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	42.32	1.55	1.16	0.00
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	28.15	2.02	0.18	0.18
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	46.81	3.90	0.00	7.80
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	38.34	0.93	0.93	0.23
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	36.25	1.81	0.00	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	29.22	1.17	0.88	0.00
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	16.27	0.46	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	30.02	4.11	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	51.87	5.53	0.61	0.31
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	64.86	0.85	0.85	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	62.78	2.12	0.91	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	62.82	4.09	0.72	0.00
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	31.41	1.34	0.67	0.22
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	28.69	2.67	0.67	0.33
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	52.03	3.72	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	63.28	1.51	2.26	1.13
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	50.16	0.87	0.00	0.44
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	78.73	1.87	3.75	0.00
adenocarcinoma cell line:IM95m	10796-110I4	47.81	2.59	0.71	0.47
adipose tissue, adult, pool1	10010-101C1	50.88	2.64	0.47	0.62
adipose, donor1	10184-103D4	34.01	0.59	0.00	0.00
adipose, donor2	10185-103D5	23.11	1.22	0.41	0.00
adipose, donor3	10186-103D6	29.95	6.26	0.27	0.00
adipose, donor4	10187-103D7	51.14	19.94	0.87	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	40.72	3.16	0.32	0.32
adrenal gland, adult, pool1	10081-102A9	36.38	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	59.63	1.60	1.07	0.53
alveolar cell carcinoma cell line:SW 1573	10708-109H6	35.02	2.86	0.36	0.36
amniotic membrane cells, donor1	12235-129G3	128.21	15.53	2.55	4.87
amniotic membrane cells, donor2	12236-129G4	108.19	9.47	1.01	2.70
amniotic membrane cells, donor3	12237-129G5	166.74	16.50	2.06	9.43
amygdala - adult, donor10196	10167-103B5	39.13	5.93	1.19	0.00
amygdala, adult, donor10252	10151-102I7	45.83	3.04	0.41	0.41
amygdala, newborn, donor10223	10360-105E9	13.88	2.90	0.00	0.97
anaplastic carcinoma cell line:8305C	10428-106D5	35.78	1.27	0.25	0.38
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	117.81	5.74	0.88	0.66
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	34.07	1.34	0.33	0.67
aorta, adult, pool1	10052-101G7	40.40	4.51	0.39	0.59
appendix, adult	10189-103D9	28.72	1.55	0.39	1.16
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	54.34	2.06	1.38	0.69
artery, adult	10190-103E1	35.33	4.08	0.00	0.00
astrocytoma cell line:TM-31	10425-106D2	58.67	2.32	0.14	0.87
b cell line:RPMI1788	10427-106D4	46.39	2.23	0.89	0.15
basal cell carcinoma cell line:TE 354.T	10702-109G9	62.70	1.11	0.28	0.83
bile duct carcinoma cell line:HuCCT1	10432-106D9	50.51	2.58	1.98	0.30
bile duct carcinoma cell line:TFK-1	10496-107C1	37.83	6.86	0.00	0.17
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	29.08	1.12	0.00	0.00
bladder, adult, pool1	10011-101C2	45.30	4.02	0.87	0.65
blood, adult, pool1	10053-101G8	1029.80	551.44	31.00	24.36
bone marrow stromal cell line:StromaNKtert	10686-109F2	38.54	0.00	0.00	1.71
bone marrow, adult	10192-103E3	44.54	2.70	3.37	0.00
brain, adult, donor1	10084-102B3	48.18	0.00	0.00	0.00
brain, adult, pool1	10012-101C3	44.54	2.78	0.22	0.33
brain, fetal, pool1	10085-102B4	40.07	5.34	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	85.89	4.96	0.99	0.99
breast carcinoma cell line:MDA-MB-453	10419-106C5	130.32	8.86	1.00	1.62
breast, adult, donor1	10080-102A8	46.72	1.89	0.63	0.63
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	55.26	5.72	0.64	0.76
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	40.82	2.16	0.31	0.31
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	22.10	1.61	0.69	0.23
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	94.17	5.33	1.45	1.45
carcinoid cell line:NCI-H1770	10703-109H1	79.93	2.35	0.00	0.00
carcinoid cell line:NCI-H727	10735-110B6	67.82	7.77	1.09	0.33
carcinoid cell line:SK-PN-DW	10719-109I8	17.11	2.22	0.00	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	38.86	2.66	0.80	0.80
caudate nucleus - adult, donor10196	10177-103C6	52.96	1.15	0.00	0.00
caudate nucleus, adult, donor10252	10164-103B2	47.86	3.68	0.84	0.00
caudate nucleus, adult, donor10258	10379-105H1	46.61	0.76	1.53	0.00
caudate nucleus, newborn, donor10223	10354-105E3	15.02	2.20	0.37	0.37
cerebellum - adult, donor10196	10173-103C2	67.01	0.00	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	57.65	2.35	0.85	0.21
cerebellum, adult, pool1	10083-102B2	36.22	1.03	0.34	0.00
cerebellum, newborn, donor10223	10357-105E6	20.76	3.32	0.00	0.00
cerebral meninges, adult	10188-103D8	36.31	3.78	0.76	0.25
cerebrospinal fluid, donor2	10294-104G6	27.04	2.92	0.73	0.73
cervical cancer cell line:D98-AH2	10552-107I3	94.47	3.45	1.29	0.86
cervical cancer cell line:ME-180	10553-107I4	68.77	9.11	2.32	1.16
cervix, adult, pool1	10013-101C4	44.62	3.25	0.42	0.84
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	67.86	2.37	1.11	0.28
chondrosarcoma cell line:SW 1353	10700-109G7	26.13	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	143.17	17.15	4.97	5.84
choriocarcinoma cell line:SCH	10785-110H2	61.48	8.13	0.99	0.99
choriocarcinoma cell line:T3M-3	10618-108G6	52.42	8.54	0.47	0.95
chorionic membrane cells, donor1	12238-129G6	94.88	11.68	1.71	3.42
chorionic membrane cells, donor2	12239-129G7	71.79	4.67	1.59	2.49
chorionic membrane cells, donor3	12240-129G8	66.49	16.48	0.55	3.85
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	23.23	0.00	1.01	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	47.83	0.77	0.77	0.19
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	62.93	2.32	1.27	1.27
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	52.39	4.37	0.77	0.26
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	62.40	3.39	0.48	0.48
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	69.23	5.29	1.43	0.61
chronic myelogenous leukemia cell line:K562	10454-106G4	93.05	5.01	0.59	0.29
chronic myelogenous leukemia cell line:KU812	10409-106B4	74.54	0.26	1.04	0.52
clear cell carcinoma cell line:JHOC-5	10638-108I8	50.52	2.06	0.00	0.46
clear cell carcinoma cell line:TEN	10636-108I6	50.32	5.90	0.87	0.35
colon carcinoma cell line:CACO-2	10513-107D9	54.18	2.93	1.65	0.18
colon carcinoma cell line:COLO-320	10420-106C6	47.13	3.80	0.38	0.00
colon, adult, donor1	10082-102B1	32.13	1.19	0.00	0.00
colon, adult, pool1	10014-101C5	44.30	1.18	0.82	0.35
colon, fetal, donor1	10070-101I7	26.57	4.94	0.62	0.00
common myeloid progenitor CMP, donor1	12130-128D6	82.50	0.00	4.58	0.00
common myeloid progenitor CMP, donor2	12134-128E1	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	53.54	1.27	0.42	0.42
cord blood derived cell line:COBL-a 24h infection	10453-106G3	58.26	0.91	2.11	0.45
cord blood derived cell line:COBL-a untreated	10449-106F8	68.11	1.41	1.41	0.28
corpus callosum, adult, pool1	10042-101F6	98.07	4.31	0.66	0.44
cruciate ligament, donor2	10295-104G7	25.94	1.62	2.43	0.00
diaphragm, fetal, donor1	10069-101I6	29.69	6.42	0.80	0.00
diencephalon, adult	10193-103E4	36.72	1.68	0.48	0.00
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	36.51	2.07	0.69	0.00
ductal cell carcinoma cell line:KLM-1	10438-106E6	69.50	10.77	0.51	0.26
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	33.46	2.89	0.48	0.00
ductus deferens, adult	10196-103E7	35.38	2.49	0.50	1.50
duodenum, fetal, donor1, tech_rep1	10071-101I8	47.53	1.44	0.00	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	42.67	3.68	1.47	0.00
dura mater, adult, donor1	10041-101F5	72.76	3.63	2.06	0.41
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	35.53	7.77	1.33	0.22
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	55.02	13.04	1.29	0.29
embryonic pancreas cell line:1B2C6	10604-108F1	41.31	6.17	0.62	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	32.69	2.12	0.00	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	34.27	4.01	0.00	0.31
embryonic pancreas cell line:2C6	10603-108E9	49.91	2.63	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	55.64	2.68	0.34	0.34
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	31.72	3.62	0.18	0.18
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	69.31	4.18	1.45	2.89
epidermoid carcinoma cell line:A431	10426-106D3	86.93	6.89	1.56	1.89
epidermoid carcinoma cell line:Ca Ski	10431-106D8	68.74	6.49	0.88	0.33
epididymis, adult	10197-103E8	45.63	5.86	1.05	1.47
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	45.59	1.77	1.06	0.00
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	20.45	1.97	0.00	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	73.91	6.16	0.92	0.79
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	67.02	6.30	1.87	1.77
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	83.01	7.28	2.91	1.01
esophagus, adult, pool1	10015-101C6	60.84	9.45	0.96	2.87
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	56.48	2.38	0.25	1.38
eye - muscle inferior rectus, donor1	10272-104E2	50.71	2.41	0.00	2.41
eye - muscle lateral, donor2	10298-104H1	27.35	8.42	0.00	0.00
eye - muscle medial, donor2	10299-104H2	14.88	4.46	0.00	0.00
eye - muscle superior, donor2	10297-104G9	21.78	3.44	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	30.61	5.83	0.00	0.00
eye, fetal, donor1	10054-101G9	73.22	4.58	1.27	0.51
fibrosarcoma cell line:HT-1080	10758-110E2	38.85	1.67	0.51	0.26
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	35.38	1.66	0.24	0.95
frontal lobe, adult, pool1	10040-101F4	54.23	2.91	0.56	0.28
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	69.66	10.51	1.50	1.20
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	97.75	5.21	1.01	0.73
gall bladder, adult	10198-103E9	38.15	1.21	1.45	0.24
gamma delta positive T cells, donor1	11937-126A2	35.97	0.54	0.54	1.07
gamma delta positive T cells, donor2	11938-126A3	45.19	0.75	1.49	0.37
gastric adenocarcinoma cell line:MKN1	10614-108G2	58.08	3.17	0.84	0.84
gastric adenocarcinoma cell line:MKN45	10612-108F9	49.90	3.48	0.58	0.19
gastric cancer cell line:AZ521	10549-107H9	48.20	3.12	0.82	0.00
gastric cancer cell line:GSS	10560-108A2	34.78	5.49	0.00	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	58.26	5.48	0.91	0.00
giant cell carcinoma cell line:LU65	10487-107B1	42.68	2.64	1.38	0.92
giant cell carcinoma cell line:Lu99B	10433-106E1	51.64	2.24	0.14	0.14
glassy cell carcinoma cell line:HOKUG	10688-109F4	93.03	10.48	4.24	3.24
glioblastoma cell line:A172, tech_rep1	10444-106F3	46.87	2.74	0.74	0.63
glioblastoma cell line:A172, tech_rep2	10444-106F3	48.17	2.25	0.56	1.12
glioblastoma cell line:T98G	10485-107A8	40.07	2.98	0.33	0.44
glioma cell line:GI-1	10413-106B8	55.65	2.34	0.59	0.59
globus pallidus - adult, donor10196	10175-103C4	48.11	3.64	0.73	0.73
globus pallidus, adult, donor10252	10161-103A8	71.52	2.93	0.24	0.00
globus pallidus, adult, donor10258	10367-105F7	45.18	5.48	0.00	0.00
globus pallidus, newborn, donor10223	10364-105F4	19.72	2.13	0.53	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	78.31	2.45	4.89	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	32.79	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	31.36	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	22.08	0.64	0.96	0.00
hIPS +CCl2, biol_rep1	14383-156B9	26.17	1.84	0.00	0.92
hIPS +CCl2, biol_rep2	14384-156C1	29.26	2.74	0.00	0.00
hIPS +CCl2, biol_rep3	14385-156C2	28.34	0.64	0.00	0.64
hIPS, biol_rep1	14380-156B6	11.50	1.44	0.00	0.00
hIPS, biol_rep2	14381-156B7	21.95	0.69	0.00	0.00
hIPS, biol_rep3	14382-156B8	30.90	1.10	0.00	1.10
hairy cell leukemia cell line:Mo	10712-109I1	31.61	0.57	0.57	0.00
heart - mitral valve, adult	10205-103F7	41.56	1.79	0.90	0.30
heart - pulmonic valve, adult	10206-103F8	32.42	1.57	0.00	0.52
heart - tricuspid valve, adult	10207-103F9	42.46	4.16	1.67	1.67
heart, adult, diseased post-infarction, donor1	10050-101G5	84.68	7.55	0.82	0.61
heart, adult, diseased, donor1	10051-101G6	71.11	1.70	0.00	0.00
heart, adult, pool1	10016-101C7	81.18	3.22	0.46	0.00
heart, fetal, pool1	10046-101G1	116.54	16.43	1.64	0.82
hepatic mesenchymal tumor cell line:LI90	10778-110G4	58.62	1.23	0.62	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	30.92	5.95	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	60.77	1.99	1.22	0.11
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	65.66	2.43	1.34	0.73
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	68.31	2.43	1.31	0.40
hepatoma cell line:Li-7	10484-107A7	45.04	2.56	1.45	0.11
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	24.92	1.31	0.50	0.00
hippocampus - adult, donor10196	10169-103B7	42.58	2.84	0.00	0.95
hippocampus, adult, donor10252	10153-102I9	49.60	3.27	0.82	0.00
hippocampus, adult, donor10258	10374-105G5	22.91	1.49	0.50	0.00
hippocampus, newborn, donor10223	10363-105F3	19.74	2.11	0.00	1.06
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	42.11	0.61	0.61	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	34.95	0.59	0.20	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	30.47	1.78	0.25	0.51
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	19.17	0.56	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	36.92	0.52	0.00	0.26
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	34.92	1.90	0.38	0.38
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	19.27	1.46	0.29	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	26.93	1.51	0.00	0.22
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	26.69	2.50	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	25.81	0.95	0.24	0.71
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	29.09	1.29	0.32	0.16
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	30.30	6.06	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	38.03	0.63	1.10	0.31
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	34.39	0.49	0.49	0.98
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	23.56	0.00	0.87	1.75
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	45.82	0.00	0.19	0.19
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	32.71	0.44	0.00	0.44
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	24.49	0.00	0.50	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	22.98	0.94	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	25.01	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	28.19	0.63	0.63	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	23.84	0.98	0.65	0.16
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	25.26	1.16	0.29	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	23.32	0.30	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	37.32	1.48	0.18	0.37
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	34.80	0.86	0.57	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	31.44	1.22	0.41	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	32.39	0.70	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	34.21	1.58	0.32	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	29.35	0.61	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	27.41	0.52	0.00	0.52
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	22.58	1.33	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	17.44	0.26	0.51	0.26
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	25.05	1.53	0.77	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	22.72	4.54	0.00	0.76
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	21.84	0.67	1.01	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	40.57	1.21	0.24	0.48
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	28.52	1.34	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	30.73	1.95	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	37.90	0.31	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	19.52	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	31.11	0.66	0.33	0.33
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	19.70	0.55	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	25.33	1.81	0.36	0.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	19.57	0.36	0.36	0.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	14.32	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	29.39	2.03	0.14	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	14.55	1.08	0.54	0.00
immature langerhans cells, donor1	11904-125F5	38.26	1.70	0.24	0.00
immature langerhans cells, donor2	11905-125F6	38.81	7.92	3.17	0.00
insula, adult, pool1	10039-101F3	61.61	3.60	0.38	0.66
keratoacanthoma cell line:HKA-1	10791-110H8	105.67	15.93	3.58	2.60
kidney, adult, pool1	10017-101C8	65.88	2.20	0.80	0.20
kidney, fetal, pool1	10045-101F9	67.62	8.56	0.92	1.27
large cell lung carcinoma cell line:IA-LM	10509-107D5	50.28	0.99	0.85	0.43
large cell lung carcinoma cell line:NCI-H460	10839-111E2	51.43	1.66	0.97	0.69
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	51.56	6.42	0.92	1.65
left atrium, adult, donor1	10079-102A7	57.75	0.54	0.00	0.00
left ventricle, adult, donor1	10078-102A6	56.63	1.52	0.51	0.00
leiomyoblastoma cell line:G-402	10721-110A1	32.29	1.64	0.55	0.27
leiomyoma cell line:10964C	10569-108B2	33.41	1.44	0.72	1.08
leiomyoma cell line:15242A	10570-108B3	35.33	2.17	2.72	2.17
leiomyoma cell line:15425	10571-108B4	28.65	2.43	0.00	0.73
leiomyosarcoma cell line:Hs 5.T	10722-110A2	50.79	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	25.09	2.09	2.09	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	53.24	0.83	1.06	0.35
liposarcoma cell line:KMLS-1	10782-110G8	14.37	0.94	0.16	0.16
liposarcoma cell line:SW 872	10726-110A6	33.26	2.44	0.24	0.37
liver, adult, pool1	10018-101C9	90.92	4.38	1.78	0.81
liver, fetal, pool1	10086-102B5	54.56	27.28	0.00	2.82
locus coeruleus - adult, donor10196	10182-103D2	32.08	1.75	0.29	0.29
locus coeruleus, adult, donor10252	10165-103B3	48.91	2.21	1.48	0.18
locus coeruleus, adult, donor10258	10375-105G6	43.17	2.54	0.28	1.13
locus coeruleus, newborn, donor10223	10362-105F2	20.19	0.84	0.84	0.84
lung adenocarcinoma cell line:A549	10499-107C4	22.84	3.74	0.69	0.42
lung adenocarcinoma cell line:PC-14	10408-106B3	57.91	6.89	0.69	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	64.72	5.40	0.13	0.26
lung, adult, pool1	10019-101D1	99.70	7.44	2.60	1.06
lung, fetal, donor1	10068-101I5	82.77	36.53	3.14	4.00
lung, right lower lobe, adult, donor1	10075-102A3	54.07	2.29	1.37	0.00
lymph node, adult, donor1	10077-102A5	54.44	1.89	1.89	0.47
lymphangiectasia cell line:DS-1	10727-110A7	116.16	8.11	3.07	2.41
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	41.81	1.81	0.15	0.00
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	77.30	5.95	1.70	0.85
mature adipocyte, donor1	12231-129F8	37.30	0.89	0.00	0.00
mature adipocyte, donor2	12232-129F9	40.68	1.25	0.42	0.00
mature adipocyte, donor3	12233-129G1	33.43	1.19	0.47	0.00
mature adipocyte, donor4	12234-129G2	37.38	2.37	0.26	0.26
maxillary sinus tumor cell line:HSQ-89	10414-106B9	70.52	9.77	0.24	0.24
medial frontal gyrus - adult, donor10196	10170-103B8	32.71	0.00	0.00	1.13
medial frontal gyrus, adult, donor10252	10150-102I6	34.94	3.31	0.74	0.55
medial frontal gyrus, adult, donor10258	10368-105F8	27.32	1.59	0.00	0.00
medial frontal gyrus, newborn, donor10223	10352-105E1	14.93	1.28	0.00	0.00
medial temporal gyrus - adult, donor10196	10183-103D3	37.46	1.69	0.17	0.51
medial temporal gyrus, adult, donor10252	10156-103A3	41.81	1.06	0.64	0.21
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	7.71	1.93	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	22.61	2.51	0.36	0.72
medulla oblongata - adult, donor10196	10174-103C3	42.18	1.95	0.65	0.00
medulla oblongata, adult, donor10252	10155-103A2	54.96	1.86	0.46	0.46
medulla oblongata, adult, pool1	10038-101F2	61.96	3.75	0.57	0.73
medulla oblongata, newborn, donor10223	10361-105F1	24.30	2.08	0.35	0.35
medulloblastoma cell line:D283 Med	10838-111E1	54.47	4.21	0.66	0.00
medulloblastoma cell line:ONS-76	10759-110E3	65.91	5.50	0.73	0.12
melanoma cell line:COLO 679	10514-107E1	33.64	4.17	1.01	0.14
melanoma cell line:G-361	10465-106H6	54.56	2.99	1.63	0.27
meningioma cell line:HKBMM	10691-109F7	37.27	2.17	0.90	0.90
merkel cell carcinoma cell line:MKL-1	10843-111E6	68.73	9.69	3.52	1.76
merkel cell carcinoma cell line:MS-1	10844-111E7	74.66	5.70	1.30	0.52
mesenchymal precursor cell - adipose, donor1	11747-123G1	32.68	1.53	0.00	0.61
mesenchymal precursor cell - adipose, donor2	11748-123G2	21.45	0.91	0.55	0.00
mesenchymal precursor cell - adipose, donor3	11749-123G3	15.74	0.83	0.41	0.41
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	28.38	0.70	0.98	0.42
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	26.38	0.96	0.39	0.19
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	34.01	2.78	0.69	0.69
mesenchymal precursor cell - cardiac, donor1	11752-123G6	43.08	2.57	1.03	0.17
mesenchymal precursor cell - cardiac, donor2	11753-123G7	29.67	0.69	0.58	0.12
mesenchymal precursor cell - cardiac, donor3	11754-123G8	33.82	1.59	0.53	0.27
mesenchymal precursor cell - cardiac, donor4	11755-123G9	58.07	2.16	0.81	0.95
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	38.55	1.00	0.85	0.43
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	48.09	0.66	0.99	0.66
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	33.07	0.97	0.28	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	34.56	1.75	0.70	0.35
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	33.07	1.63	0.61	0.20
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	28.76	1.44	0.72	0.36
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	30.83	0.52	0.00	0.21
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	26.45	2.51	0.68	0.46
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	28.95	2.10	0.00	1.68
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	31.98	1.64	0.45	0.60
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	31.51	0.88	0.53	0.70
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	29.08	1.84	0.74	0.37
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	30.62	0.29	1.43	1.43
mesenchymal stem cell line:Hu5/E18	10568-108B1	31.58	0.84	0.84	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	19.64	0.46	0.91	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	24.04	1.53	0.26	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	26.44	0.00	0.26	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	21.26	0.92	0.31	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	19.53	0.24	0.71	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	22.34	0.34	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	22.01	0.79	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	12.51	0.00	0.46	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	25.67	0.58	0.87	0.29
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	22.98	0.67	0.22	0.22
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	22.35	0.72	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	21.27	0.00	0.73	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	17.12	1.01	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	13.10	0.41	0.41	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	13.32	0.00	0.43	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	19.14	2.73	2.73	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	15.49	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	19.49	0.97	0.32	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	23.28	1.45	0.00	1.45
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	17.59	0.53	1.07	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	19.63	0.82	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	18.66	1.17	0.78	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	14.69	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	5.96	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	23.84	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	16.01	2.37	0.59	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	12.18	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	27.05	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	14.57	0.63	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	21.38	0.34	0.00	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	21.49	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	7.98	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	20.66	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	24.86	0.41	0.41	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	23.83	0.79	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	16.51	1.77	0.59	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	22.13	0.94	0.62	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	17.38	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	24.84	1.18	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	10.27	2.57	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	30.29	0.00	0.00	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	38.10	1.98	0.99	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	34.77	2.24	1.12	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	34.98	1.27	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	42.31	2.42	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	47.97	2.18	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	35.48	1.27	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	34.59	0.61	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	49.71	4.52	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	42.83	3.29	0.00	0.82
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	26.99	0.99	0.20	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	22.71	0.32	0.32	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	26.48	0.00	0.00	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	53.39	0.00	0.00	0.77
mesothelioma cell line:ACC-MESO-1	10493-107B7	64.97	5.91	0.24	0.00
mesothelioma cell line:ACC-MESO-4	10494-107B8	49.35	3.01	1.16	1.16
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	34.19	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	21.78	1.34	0.31	0.00
mesothelioma cell line:Mero-25	10850-111F4	24.96	1.36	0.23	0.45
mesothelioma cell line:Mero-41	10851-111F5	44.25	2.93	0.00	0.24
mesothelioma cell line:Mero-48a	10852-111F6	33.66	1.99	0.44	1.33
mesothelioma cell line:Mero-82	10853-111F7	28.91	1.84	0.79	0.00
mesothelioma cell line:Mero-83	10854-111F8	32.85	1.02	0.17	0.34
mesothelioma cell line:Mero-84	10855-111F9	40.44	3.03	0.25	0.25
mesothelioma cell line:Mero-95	10856-111G1	46.17	3.11	0.41	1.04
mesothelioma cell line:NCI-H2052	10847-111F1	33.63	2.32	0.83	0.83
mesothelioma cell line:NCI-H226	10846-111E9	24.43	1.63	0.36	0.54
mesothelioma cell line:NCI-H2452	10848-111F2	24.94	0.51	0.51	0.68
mesothelioma cell line:NCI-H28	10845-111E8	24.17	3.05	0.25	0.51
mesothelioma cell line:No36	10857-111G2	34.90	2.28	0.65	0.33
mesothelioma cell line:ONE58	10858-111G3	30.08	0.27	0.81	0.54
migratory langerhans cells, donor1	11901-125F2	30.13	0.96	0.19	0.38
migratory langerhans cells, donor2	11902-125F3	35.29	0.49	0.24	0.00
migratory langerhans cells, donor3	11903-125F4	32.31	0.36	0.18	0.00
mixed mullerian tumor cell line:HTMMT	10689-109F5	45.38	4.24	0.65	0.00
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	36.03	1.91	0.00	0.21
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	72.33	6.22	1.61	0.69
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	42.82	0.76	0.57	0.19
myelodysplastic syndrome cell line:SKM-1	10772-110F7	82.60	3.33	0.74	0.37
myeloma cell line:PCM6	10474-106I6	54.36	1.58	0.99	1.19
myxofibrosarcoma cell line:MFH-ino	10600-108E6	34.50	1.52	0.51	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	50.02	1.96	0.39	0.39
nasal epithelial cells, donor1, tech_rep1	12226-129F3	96.49	10.25	4.01	1.23
nasal epithelial cells, donor1, tech_rep2	12226-129F3	78.84	10.88	2.94	1.47
nasal epithelial cells, donor2	12227-129F4	79.49	8.83	1.66	1.66
neuroblastoma cell line:CHP-134	10508-107D4	61.43	3.45	0.69	0.23
neuroblastoma cell line:NB-1	10539-107G8	140.13	4.30	3.37	0.37
neuroblastoma cell line:NBsusSR	10607-108F4	35.22	6.12	0.42	0.00
neuroblastoma cell line:NH-12	10555-107I6	39.32	2.05	0.19	0.37
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	40.09	4.98	0.24	0.00
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	30.73	3.17	0.32	0.00
neuroectodermal tumor cell line:TASK1	10774-110F9	49.31	2.62	0.40	0.00
neuroepithelioma cell line:SK-N-MC	10728-110A8	45.14	5.09	0.00	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	37.53	1.06	0.00	0.00
neutrophil PMN, donor1	12133-128D9	252.87	0.00	14.87	0.00
neutrophil PMN, donor2	12137-128E4	106.25	26.56	0.00	0.00
neutrophil PMN, donor3	12141-128E8	85.24	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	82.19	1.18	1.35	0.17
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	155.30	18.41	2.40	0.80
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	36.55	1.92	0.32	0.64
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	34.16	2.63	0.53	0.00
nucleus accumbens, adult, pool1	10037-101F1	67.68	2.91	0.66	0.47
occipital cortex - adult, donor10196	10172-103C1	28.85	2.06	2.06	0.00
occipital cortex, adult, donor10252	10163-103B1	46.70	2.95	0.27	0.27
occipital cortex, newborn, donor10223	10355-105E4	14.56	1.46	0.73	0.00
occipital lobe, adult, donor1	10076-102A4	51.17	2.36	0.52	0.79
occipital lobe, fetal, donor1	10073-102A1	43.77	3.43	0.86	0.00
occipital pole, adult, pool1	10036-101E9	55.19	2.52	0.79	0.47
olfactory region, adult	10195-103E6	30.00	2.10	0.38	0.19
optic nerve, donor1	10277-104E7	28.01	6.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	70.51	4.44	2.39	1.48
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	81.74	3.30	0.14	0.14
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	59.77	4.40	1.52	0.85
oral squamous cell carcinoma cell line:SAS	10544-107H4	46.20	3.93	1.04	0.92
osteoclastoma cell line:Hs 706.T	10704-109H2	34.10	2.65	0.29	0.88
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	56.06	3.74	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	40.93	4.24	0.64	0.64
ovary, adult, pool1	10020-101D2	41.49	4.28	0.35	0.87
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	40.88	2.02	0.37	0.18
pancreas, adult, donor1	10049-101G4	126.99	5.64	0.94	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	60.38	7.55	1.96	2.24
papillary adenocarcinoma cell line:8505C	10437-106E5	39.01	2.73	1.53	1.53
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	47.85	3.31	1.32	0.83
paracentral gyrus, adult, pool1	10035-101E8	57.20	3.11	0.73	0.73
parietal cortex, adult, donor10258	10373-105G4	28.63	6.61	0.00	0.73
parietal lobe - adult, donor10196	10171-103B9	28.21	1.88	0.00	0.94
parietal lobe, adult, donor10252	10157-103A4	39.91	2.85	0.29	0.86
parietal lobe, adult, pool1	10034-101E7	61.51	1.85	0.88	0.44
parietal lobe, fetal, donor1	10072-101I9	29.10	0.97	0.00	0.97
parietal lobe, newborn, donor10223	10356-105E5	22.43	3.36	0.00	1.12
parotid gland, adult	10199-103F1	98.05	10.48	0.00	0.00
penis, adult	10200-103F2	32.76	0.00	0.00	0.00
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	28.63	5.39	0.00	0.37
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	59.59	3.93	0.44	0.29
pineal gland - adult, donor10196	10179-103C8	37.41	3.87	1.29	0.00
pineal gland, adult, donor10252	10160-103A7	86.46	3.55	1.18	1.18
pineal gland, adult, donor10258	10377-105G8	36.37	0.00	0.00	1.25
pituitary gland - adult, donor10196	10180-103C9	62.73	3.04	0.00	0.00
pituitary gland, adult, donor10252	10162-103A9	89.12	2.61	0.52	1.04
pituitary gland, adult, donor10258	10378-105G9	23.83	1.70	0.00	0.00
placenta, adult, pool1	10021-101D3	90.19	24.40	1.08	5.05
plasma cell leukemia cell line:ARH-77	10840-111E3	43.57	1.85	0.66	0.26
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	61.94	5.60	1.40	0.62
pons, adult, pool1	10033-101E6	46.39	1.64	0.69	0.52
postcentral gyrus, adult, pool1	10032-101E5	57.01	2.18	0.78	0.09
promyelocytes/myelocytes PMC, donor1	12132-128D8	50.19	6.27	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	33.05	0.00	5.51	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	60.01	4.37	1.46	0.44
prostate cancer cell line:PC-3	10439-106E7	98.01	4.54	1.45	0.54
prostate, adult, pool1	10022-101D4	46.07	4.26	0.36	1.09
putamen, adult, donor10196	10176-103C5	58.78	4.96	0.00	0.00
putamen, adult, donor10252	10152-102I8	33.33	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	18.58	2.19	0.00	1.09
putamen, adult, donor10258, tech_rep2	10372-105G3	39.62	2.17	0.97	0.72
putamen, newborn, donor10223	10365-105F5	12.74	0.75	0.75	0.00
rectal cancer cell line:TT1TKB	10469-106I1	34.33	6.11	1.45	1.45
rectum, fetal, donor1	10067-101I4	40.34	1.39	0.00	1.39
renal cell carcinoma cell line:OS-RC-2	10411-106B6	53.21	3.60	0.21	0.42
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	55.09	5.80	0.00	1.24
retina, adult, pool1	10030-101E3	97.41	7.85	1.19	0.99
retinoblastoma cell line:Y79	10475-106I7	68.33	4.42	2.08	0.52
rhabdomyosarcoma cell line:KYM-1	10787-110H4	48.32	2.70	0.37	0.12
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	62.43	5.06	0.56	0.00
sacrococcigeal teratoma cell line:HTST	10695-109G2	25.01	0.76	1.52	0.00
salivary acinar cells, donor1	11771-123I7	30.75	2.59	0.32	1.13
salivary acinar cells, donor2	11772-123I8	39.93	3.58	0.96	1.51
salivary acinar cells, donor3	11773-123I9	54.95	10.59	0.00	3.97
salivary gland, adult, pool1	10093-102C3	74.35	9.15	1.14	1.14
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	30.35	1.01	0.84	0.93
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	39.26	1.53	0.71	0.35
seminal vesicle, adult	10201-103F3	35.98	1.59	0.53	0.00
serous adenocarcinoma cell line:JHOS-2	10639-108I9	42.27	3.89	1.94	0.49
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	30.45	2.26	1.01	0.00
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	45.16	1.00	1.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	55.74	5.91	1.21	0.94
signet ring carcinoma cell line:Kato III	10436-106E4	56.48	5.08	1.11	0.44
signet ring carcinoma cell line:NUGC-4	10483-107A6	38.19	2.06	0.13	0.13
skeletal muscle - soleus muscle, donor1	10282-104F3	22.70	4.26	0.71	0.00
skeletal muscle, adult, pool1	10023-101D5	56.73	4.44	1.08	0.60
skeletal muscle, fetal, donor1	10066-101I3	50.25	14.07	2.01	2.01
skin, adult, donor1	10074-102A2	101.78	6.79	0.00	0.00
skin, fetal, donor1	10065-101I2	54.92	9.47	1.26	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	110.06	11.34	2.33	0.67
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	52.64	3.15	0.63	0.32
small cell lung carcinoma cell line:DMS 144	10841-111E4	43.95	5.40	0.19	0.77
small cell lung carcinoma cell line:LK-2	10541-107H1	80.60	1.65	1.48	0.49
small cell lung carcinoma cell line:NCI-H82	10842-111E5	150.23	13.99	0.80	0.32
small cell lung carcinoma cell line:WA-hT	10562-108A4	80.63	9.59	0.87	1.31
small intestine, adult, pool1	10024-101D6	59.12	6.21	0.72	0.96
small intestine, fetal, donor1	10064-101I1	31.94	1.72	0.49	1.23
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	69.24	7.18	2.56	0.00
smooth muscle, adult, pool1	10048-101G3	29.46	0.26	0.78	0.00
somatostatinoma cell line:QGP-1	10781-110G7	55.75	4.02	0.00	0.54
spinal cord - adult, donor10196	10181-103D1	42.44	0.92	0.92	0.69
spinal cord, adult, donor10252	10159-103A6	46.52	1.58	1.18	0.79
spinal cord, adult, donor10258	10369-105F9	33.21	3.46	0.00	0.00
spinal cord, fetal, donor1	10056-101H2	54.89	5.49	0.61	0.61
spinal cord, newborn, donor10223	10359-105E8	21.12	2.30	0.46	0.00
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	44.81	2.24	0.60	0.15
spleen, adult, pool1	10025-101D7	72.58	3.30	2.09	0.66
spleen, fetal, pool1	10044-101F8	111.16	43.78	3.26	3.50
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	39.23	1.04	1.35	0.00
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	80.51	5.51	0.19	0.76
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	102.04	10.83	1.75	3.15
squamous cell carcinoma cell line:T3M-5	10616-108G4	44.57	3.13	1.95	1.17
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	48.85	4.28	1.46	0.68
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	50.41	5.08	0.42	0.85
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	41.04	2.54	0.42	0.00
stomach, fetal, donor1	10062-101H8	79.03	4.27	2.14	2.14
submaxillary gland, adult	10202-103F4	62.66	8.55	0.00	0.57
substantia nigra - adult, donor10196	10178-103C7	108.55	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	48.19	2.91	0.42	0.42
substantia nigra, adult, donor10258	10371-105G2	24.83	1.55	0.00	0.52
substantia nigra, newborn, donor10223	10358-105E7	21.20	2.12	0.00	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	60.07	2.98	0.23	0.46
temporal lobe, adult, pool1	10031-101E4	59.25	2.63	0.68	0.51
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	52.00	11.40	0.00	0.71
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	26.81	5.71	0.44	0.88
tenocyte, donor1	11763-123H8	42.59	1.40	1.05	1.05
tenocyte, donor2	11765-123I1	33.95	1.91	0.76	1.14
tenocyte, donor3	11768-123I4	32.99	0.74	0.00	0.74
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	71.21	3.40	0.68	0.68
teratocarcinoma cell line:NCR-G1	10798-110I6	93.41	9.71	1.23	1.70
teratocarcinoma cell line:PA-1	10807-111A6	50.99	1.86	0.46	0.46
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	88.74	6.47	1.90	0.63
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	62.78	7.94	0.38	0.00
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	88.34	6.98	1.42	0.33
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	61.88	12.70	1.63	0.65
testis, adult, pool1	10026-101D8	78.70	5.80	2.79	2.15
testis, adult, pool2	10096-102C6	67.21	5.86	3.16	1.35
thalamus - adult, donor10196	10168-103B6	45.26	1.10	0.00	0.00
thalamus, adult, donor10252	10154-103A1	51.26	1.72	0.16	0.16
thalamus, adult, donor10258, tech_rep1	10370-105G1	21.55	3.08	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	31.95	1.48	0.33	0.16
thalamus, newborn, donor10223	10366-105F6	11.51	0.00	0.00	0.00
throat, adult	10209-103G2	51.18	3.25	0.25	3.50
throat, fetal, donor1	10061-101H7	49.97	7.31	0.61	0.91
thymic carcinoma cell line:Ty-82	10803-111A2	43.32	4.37	0.00	0.40
thymus, adult, pool1	10027-101D9	48.42	2.09	1.69	0.40
thymus, fetal, pool1	10043-101F7	68.06	6.13	2.18	0.52
thyroid carcinoma cell line:KHM-5M	10776-110G2	28.85	1.73	0.13	0.13
thyroid carcinoma cell line:TCO-1	10783-110G9	54.06	4.47	0.98	1.40
thyroid, adult, pool1	10028-101E1	59.81	5.13	0.00	0.56
thyroid, fetal, donor1	10060-101H6	40.08	3.43	0.00	0.26
tongue epidermis (fungiform papillae), donor1	10288-104F9	52.35	9.24	0.00	0.00
tongue, adult	10203-103F5	48.84	3.26	2.09	1.86
tongue, fetal, donor1	10059-101H5	56.36	3.94	0.00	0.79
tonsil, adult, pool1	10047-101G2	74.43	6.51	1.60	1.80
trachea, adult, pool1	10029-101E2	79.34	6.46	1.15	1.96
trachea, fetal, donor1	10058-101H4	62.32	13.85	0.77	1.54
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	27.28	1.77	1.06	0.00
transitional-cell carcinoma cell line:5637	10418-106C4	53.80	2.23	0.41	0.10
transitional-cell carcinoma cell line:JMSU1	10492-107B6	40.11	1.25	0.47	0.47
tridermal teratoma cell line:HGRT	10694-109G1	9.51	3.81	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	30.73	2.12	0.59	0.42
umbilical cord, fetal, donor1	10057-101H3	60.51	6.26	0.00	2.09
uterus, adult, pool1	10100-102D1	26.62	1.02	0.51	0.34
uterus, fetal, donor1	10055-101H1	33.28	1.54	2.05	1.54
vagina, adult	10204-103F6	30.37	7.11	0.65	1.29
vein, adult	10191-103E2	32.44	1.53	0.44	0.44
xeroderma pigentosum b cell line:XPL 17	10563-108A5	29.64	0.27	0.27	0.00

Property "Nearest transcripts" (as page type) with input value "ENST00000367254.7:-11 AY424279:13 AK222503:-17 AF151803:-28 BC010743:-30 ENST00000426229.1:-32 BC001594:-36 ENST00000340990.10:-59 NM_015999.6:-59 AK001484:-59 AK058114:-59 LF205361:-142 MA440938:-142 NM_001290557.1:-143 NM_001290553.2:261 ENST00000417068.5:-319 NM_001290629.1:-319" contains invalid characters or is incomplete and therefore can cause unexpected results during a query or annotation process.